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ABSTRACT 	 1. 
A new rapid method.of human erythrocyte age fractionation was 
developed using ipycnic centrifugation through gradients of 
"Percoll" a commercially available polyvinyl-pyrrolidone coated 
colloidal silica. The effectiveness of the system was demonstrated 
by the distribution of reticulocytes on the gradient and by showing 
density related changes in a selection of parameters which have 
previously been associated with ageing: erythrocyte volume, 
haemoglobin concentration, potassium content, pyruvate kinase and 
acetylcholinesterase activities. 
The technique was used to age fractionate erythrocytes-from patients 
with hereditary spherocytosis (HS), the most common inherited 
haemolytic anaemia. in peoples of Northern European origin. As the 
above age related parameters may be altered in these abnormal cells 
age fractionation was proven by the correlation of increased 
osmotic fragility (known to increase with age) with increasing 
density, cell morphology and the distribution of reticulocytes on 
the gradient. 
Using age fractionation. to compare normal and HE erythrocytes of 
similar age the cause of decreased cell lifespan in HS was examined. 
There was no gross. evidence of metabolic insufficiency in the 
intracellular enzyme pyruvate kinase though interpretation of the 
data was complicated by abnormally high activity in HS. In 
contrast examination of the membrane associated parameters, 
acetyicholinesterase activity and cell potassium content, revealed 
a rapid loss of.. function which was not entirely corrected by 
splenectomy. 
Analysis of the HE erythrocyte membrane by SDS-PAGE and cell 
surface iodination revealed no abnormality in cells of any age. An 
unidentified Comassie band of apparent molecular weight 68,000 
present only in the oldest normal erythrocytes was also present in 
the oldest HS erythrocytes both before and after splenectomy again 
suggesting a rapid ageing of the membrane. The significance of the 
above findings in the understanding of HE is discussed. 
2. 






































CONSIDERATION AND PROBLEMS IN THE STUDY 
	
31. 
OF ABNORMAL. ERYTHROCYTES 
3. 
1.1 	PERSPECTIVE 
"Clinical haematology exemplifies the ways in which 
clinical medicine has fed the basic sciences with 
questions and with clues, and the basic sciences 
in turn have illuminated human disease". (M.M. Wintrobe 
1974). 
This statement is especially applicable to the 
molecular biology of the erythrocyte which over the 
last 30 years has provided a basic knowledge of the 
structure, function and arrangement of the component 
molecules of the red cell, both normal and abnormal. 
Now attention is turning to detail and to the 
dynamic aspects of the cell's existence: a molecular 
picture of erythrocyte production, ageing (i.e. the 
molecular changes occurring during the cell's 
sojourn in the circulation) and eventual destruction 
is being sought. Again the interplay of a basic 
understanding of the normal cell with the 
description of abnormal states is proving to be of 
value. 
This thesis is a study, in the light of current 
techniques and understanding, of the ageing of 
normal erythrocytes and erythrocytes from persons 
with hereditary spherocytosis, the most common 
genetically determined erythrocyte defect in 
Northern Europeans. 
1.2 	ERYTHROCYTE PRODUCTION 	 4 
Erythropoiesis begins in the embryo and, due to the 
finite existence of the anucleate mature red cell, 
continues throughout life. In adult mammals 
erythrocyte production occurs in the bone marrow. 
The process is well described by Wrickramasinghe (1975). 
Basically, with appropriate stimuli, a common stem cell 
becomes a pronorinoblast, the earliest recognisable 
erythrocyte precursor. The pronormoblast undergoes 
on average four mitoses during which time components 
of the mature erythrocyte are sequentially-synthesised. 
(See for example Chang et al 1977). Then, in a process 
which in some ways resembles mitosis, the cellular 
components are rearranged and the cell divides into a 
membrane bound nucleus and an anucleate, polylobed 
motile segment, the immature reticulocyte. The 
molecular rearrangement is such that the two products 
have different surface properties (Stuteisky and 
Farquhar 1976; Light and Tanner 1977; Geidushek and 
Singer 1979). This difference presumably has 
bearing on the respective fates of the two products: 
the nuclear segment is immediately phagocytosed 
whilst the reticulocyte enters the circulation, 
normally after 1 - 2 days maturation . in the bone 
marrow. During maturation the reticulocyte becomes 
biconcave, possibly through a uniconcave intermediate 
(Mel. et al 1977), and loses most of its residual 
cytoplasmic organelles. The remainder, along with 
some plasma membrane material, are lost during the 
first 1 - 2 days in the circulation in a process 
thought to involve the spleen (Groom et al 1971; 
Shattil and Cooper 1972) and the cell is then 
classed as an erythrocyte. 
1.3 	ERYTHROCYTE STRUCTURE 	 5 
The mature erythrocyte is a biconcave disc 
approximately 8 x 2.5p comprising a plasma membrane 
(usually termed the erythrocyte membrane due to the 
cell's lack of internal membranes) specialised for the 
circulatory existence of the cell, and an inclusion-free 
cytoplasm which contains approximately 95% haemoglobin 
(dry weight). and enzymes and metabolites necessary to 
the erythrocytes function. The erythrocyte membrane due 
to its ready availability in pure form has been 
extensively studied, "an essential workhorse for membrane 
data". (Nicholson 1976), and reviewed (Steck 1974; 
Marchesi et. al 1976; Marchesi. 1979; Gratzer 1981). 
Briefly, the membrane comprises 52% (w/w) protein, 
40% lipid and 8% carbohydrate (of which 7% is 
glycosphingolipid and 93% glycoprotein). The lipid is 
organised in an asymmetric bilayer with sphingomyelin, 
phosphatid.ylcholine, glycosphingolipids and possibly 
cholesterol predominantly in the outer (exterior) half 
of bilayer and phosphatidylserine, 
phosphatidylethanolamine, and. phosphatidylinositol 
predominantly in the cytoplasmic half. The protein is 
associated. with the bilayer in two ways. Integral 
membrane proteins penetrate or traverse the bilayer 
and interact with the hydrophobic lipid core whilst 
peripheral proteins interact with lipids or proteins 
at the membrane surface. About 25 bands can be resolved 
by one-dimensional polyacrylamide gel electrophoresis 
in the presence of.SDS and these are generally referred 
to by the terminology of Fairbanks et al (1971) 
(See Figure 5.1 for illustration). 
Of particular interest are the proteins comprising 
the membrane skeleton (reviewed by Lux 1979a) which 
is thought to maintain the integrity, flexibility 
and shape of the erythrocyte membrane during its life 
in the turbulent circulation. This membrane skeleton, 
or cytoskeleton, is operationally defined as the 
proteinaceous structure remaining after extraction 
of ghosts of intact erythrocytes with non-ionic 
detergents such as Triton X-100. Its components are 
bands 1, 2 (which form .a heterodimer, spectrin), 
2.1, 2.2, 2.3, 2.6 (syndein, the latter 3 bands being 
proteolytic degradation products of 2.1), 4.1, 5 
(erythrocyte actin) and part of bands 3, 4.2, 4.9 and 7. 
The current model of the skeleton.envisages spectrin 
heterodimers joined head to head to form long flexible 
bisfunctional spectrin tetramer strands which are 
crosslinked at each end, through interactions of 
uncertain stochiometry, with actin (possibly arranged 
in short filaments) and band 4.1.. This network is 
thought to be linked to 10-20% of the principal band 
3 protein (the anion channel) by syndein, which binds 
0 
to spectrin at a site 200 A distal to the end involved 
in the dimer-tetramer interaction. Again the 
stochiometry of the interaction is unclear as are the 
positions and functions of bands 4.2, 4.9 and 7, and 
the role of phosphorylation of many of the skeletal 
components. Syndein, bands 4.1, 4.9 and 7 are 
phosphorylated in cyclic AMP dependent reactions 
whilst band 2 of, spectrin and band 3 are 
phosphorylated by cyclic AMP independent kinases. 
Lux (1979b) has reviewed the evidence of the function 
of this skeleton which, in addition to maintaining 
erythrocyte shape, deformability and structural 
integrity appears to influence the distribution of 
membrane proteins and lipids. The skeleton immobilises 
integral membrane proteins in a diffuse distribution 
7. 
preventing such events as membrane fusion. It may also 
keep the inner bilayer more fluid than the outer and help 
preserve phospholipid asymmetry. 
1.4 	ERYTHROCYTE METABOLISM 	 8. 
Though the erythrocyte has a more limited metabolism 
than nucleated cells it is not, as was once thought, 
metabolically inert. Rather it has a metabolism 
specialised-for-its primary function, oxygen transport. 
Erythrocyte metabolism, is discussed by many authors 
e.g. Harris and Kelermeyer (1970).:.Beutler (1978). 
Energy. is derived from plasma glucose which enters the 
cell by facilitated transport. About 90% of this is 
metabolised by anaerobic glycolysis and its side 
pathway the Rapoport-Luebering shunt which produces 
2,3-DPG, an important modulator of haemoglobin oxygen 
affinity. The remainder enters the hexose 
monophosphate shunt. These pathways are inter-related 
by the transkelolase and transaldolase reactions 
and their relative activity is thought to be regulated 
by the concentration of oxidised glutathione: as this 
increases more glucose enters the hexose 
monophosphate shunt. 
The "high energy" compounds produced by the aforesaid 
reactions are utilised in four main ways. 
Biosynthesis. The erythrocyte has a limited 
biosynthetic capability. It can form glycogen 
though the balance of reactions is such that 
glycogen is not stored. Glutathione is formed 
from.cysteine, glycine and glutamic acid; membrane 
lipid from malonyl CoA and plasma lipids; 
nucleotide and coenzyme from preformed base. 
Active transport. AT? is required for active 
transport processes such as Na+/K+ pumping, and the 
extrusion of Ca and oxidised glutathione. 
9. 
Maintenance of reduced state. As a carrier of 
molecular oxygen the erythrocyte is susceptible to 
oxidation and has a number of mechanisms to 
maintain its components, notably haemoglobin, in a 
functional.reduced state. Methaemoglobin (Fe +++ 
is mainly reduced by MADE. via methaemoglobin 
reductase. Cellular oxidants e.g. H 2  0 2 
 are reduced 
by glutathione and the oxidised glutathione so 
produced is reduced by NADPH in a reaction 
catalysed by glutathione reductase. This enzyme 
also catalyses the reduction. of haemoglobin-
glutathione mixed disulphides. 
Maintaining membrane durability and pliancy. This 
is achieved by the erythrocyte cytoskeleton 
(Section 1.3), the properties of which are thought 
to be regulated by a poorly understood system of 
phosphorylation and. dephosphorylation reactions, 
involving AT? as.well as intracellular calcium 
levels. (For review see Palek and Liu, 1979). 
In. addition to the enzymes involved in the above 
reactions, many other enzyme activities often of 
uncertain function have been found in the 
erythrocyte, e.g. remnants of TCA cycle enzymes, 
carbonic anhydrase. (involved in CO  transport), 
proteolytic enzymes, superoxide dismutase and 
acetylcholinesterase. 
Many mutants of metabolism have been reported in 
human. erythrocytes (reviewed by Beutler 1979; 
Valentine 1979). Correlation of the clinical and 
haematological effects of a mutation with the 
molecular defect can be of use in demonstrating the 
in vivo importance of reactions and control 
mechanisms. Control of erythrocyte metabolism is 
of course complex and only beginning to be 
understood. (See for example Fornaini 1967; 
Badwey and Westheád 1978; Aragon et al 1980). 
10. 
11. 
1.5 	ERYTHROCYTE. AGEING AND DESTRUCTION 
The mature erythrocyte with its limited biosynthetic 
ability has a finite existence. Studies of 
erythrocyte lifespan in humans have demonstrated that 
the cells survive for approximately 120 days after which 
they disappear from the circulation. (Reviewed by 
Wintrobe 1974, Chapter 5). Random destruction (i.e. 
destruction regardless of age) is minimal in normal 
humans, but may increase in disease. 
Little is known about the site and mechanism of 
destruction of normal erythrocytes (Wrickramasinghe 1975). 
It is generally assumed that effete red cells are 
phagocytosed by cells of the reticuloendothelial 
system, though whether the cells are phagocytosed intact 
or after fragmentation or lysis is unclear. The 
relative importance of the various reticuloendothelial 
organs (liver, bone marrow, spleen, lymph nodes) in 
normal erythrocyte destruction is also unclear. In 
abnormal states the site of destruction is influenced 
by the degree of cell damage (Klausner et al 1975). 
Severely damaged erythrocytes are destroyed in all parts 
of. the reticuloendothelial system, but especially in 
the liver because of its relatively, large blood flow. 
Mildly abnormal erythrocytes are mainly destroyed in 
the spleen. 	 - 
Analyses of age fractionated erythrocytes have 
indicated, that many changes occur (collectively termed 
ageing) during the cell's time in the circulation. 
(Summarised by Fornaini 1967; Wintrobe 1974, p201). 
Briefly, metabolic activity declines with a decreased 
activity of many glycolytic, hexose monophosphate 
shunt and miscellaneous enzymes. The cellular contents 
of ATP and 2,3-DPG are reduced though ATP 
concentration remains constant (Kirkpatrick et al 1979, 
12. 
see below). Haemoglobin is altered: methaemoglobin 
(Keitt et al 1966), glycosylated haemoglobin (Bunn et 
al 1978) and. oxygen affinity (Haidas et al 1971) all 
increase with age. Loss of membrane components occurs 
(See Section 5.1 for discussion). Erythrocyte cations 
are altered: K+  decreases,  Na+  possibly increases (Cohen 
et al 1976) and the distribution of Ca between membrane 
and cytoplasm is changed (Schrier et al 1980). The above 
changes are reflected in a decrease of cell size and 
increase in density. 
In spite of this detailed. knowledge the mechanism by 
which the effete erythrocyte is destroyed is still 
unknown. In general terms, molecular changes in the aged 
erythrocyte must lead to its recognition and subsequent 
sequestration by the recticuloendothelial system. The 
major hypotheses to be advanced concerning, the nature of 
these changes are as follows: 
1: Metabolic Insufficiency 
It has long been considered likely that, in the 
absence of protein synthesis, gradual deterioration 
of erythrocyte metabolisrn.will eventually lead to 
a critical, shortage of ATP or reducing power 
resulting in cell damage and recognition by 
phagocytes. However there is no striking evidence 
of such a deficiency. For. example Keitt et al (1966) 
found no appreciable loss.in the ability of old 
red blood cells to reduce methaemoglobin under 
physiological conditions. A report by Brok et al 
(1966) of extremely low hexokinase.activity and AT? 
level in the densest (oldest). 1% of erythrocytes has 
not been.substantiated.. Indeed Kirkpatrick and co-
authors (1979) have reported that..the densest 1% of 
circulating erythrocytes contain normal 
concentration of ATP, even though the content is 
13. 
decreased due to decreased cell volume. Thus either 
metabolically inadequate cells are rapidly removed 
from the circulation, the lethal changes are 
subtle, age fractionation systems do not purify 
the oldest. erythrocytes sufficiently or metabolic 
insufficiency is not a prerequisite for cell death. 
Erythrocyte Surface Charge 
The role of surface charge in erythrocyte 
destruction has recently been reviewed by Nordt 
(1980). Heconcludes on. the basis of recent 
electrophoretic studies and sialic acid levels per 
surface area that earlier reports (e.g. Yaari 1969) 
of decreased surface charge density with age are 
invalid. Rather it appears that surface charge 
density remains constant though surface charge 
topography may alter, causing recognition of 
senescent erythrocytes by the reticuloendethelial 
system. This has yet to be proven. 
"Physiological" autoantibody 
It has been suggested (Kay 1975, 1978) that changes 
in the erythrocyte surface.result in the binding 
of physiological autoantibody which allows 
recognition of aged erythrocytes by phagocytes. 
Kay demonstrated low levels of IgG on old 
erythrocytes.and their increased susceptability to 
phagocytosis by autologous.macrophages. Recently 
(1981) she used these IgG autoantibodies eluted from 
senescent erythrocytes to isolate and purify the IgG 
binding antigen. This appears to be a 
sialoglycopeptide of approximately 62,000 molecular 
weight. Alderman et al (1980) also found Ig (mainly 
IgG but also 1gM and IgA) on the most dense (oldest) 
14. 
3-5% of erythrocytes and showed immunologically that 
the Ig reacts against asialoglycophorin (Alderman 
et al 1981). However Szymanski et al (1980) found 
IgG on the surface of all.red cells and showed by 
study of abnormal.states that the amount is dependent 
on the concentration of Ig in the plasma and the 
duration of the cells' existence in the circulation. 
These authors wonder if the bound IgG has any 
biological function and point out that in acquired 
autoimmunity erythrocytes can survive with large 
amounts of surface bound IgG. Work in this 
laboratory in conjunction with Dr. K. James and co-
workers (Dept. of Surgery, Edinburgh University) 
detected IgG on all erythrocytes by radioimmune assay, 
the largest amounts being found on the youngest and 
oldest cells. It was also found that radiolabelled 
IgG prepared from an individual bound significantly 
to the same individual's erythrocytes when added 
just prior to a standard washing procedure. Thus the 
role (if any) of Ig on aged erythrocytes has still to 
be elucidated. 
4: Desialation 
Following Ashwell and Morell's (1974) work on the 
clearance, of serum asialoglycoproteins and the 
general agreement that the sialic acid content of old 
erythrocytes is 10 to 15%.lower than that of young, it 
was hypothesised that desialation leading to exposure 
of galactosyl residues on the senescent erythrocyte 
may lead to its recognition and sequestration by the 
reticuloendothelial system. However there is no clear 
evidence for this hypothesis. Various authors (e.g. 
Kadlubowski and Agutter 1977) have pointed out that 
sialic acid levels per cell surface area do not 
decrease with erythrocyte age and Lutz and Fehr (1979) 
15. 
report that glycophorins extracted. from young and 
old erythrocytes have, with an error of 1.5%, the 
same sialic acid content. Also Skuteisky et al (1977) 
find that peanut lectin (specific for terminal non-
reducing D-galactosyl residues) does not bind to 
human erythrocytes. Conflicting results have been 
obtained with animal models. A number of groups (e.g. 
Durocher et al 1975) have shown that sialidase treated 
mammalian erythrocytes are rapidly removed from the 
circulation and Kolb et al (1978) have demonstrated 
desialated rat erythrocyte - liver cell adherence 
in vitro mediated by a galactose specific membrane 
receptor. However Bell et al (1977) found that the 
decreased viability of sialidase treated dog and 
rabbit erythrocytes was not due to exposure of 
galactosyl residues. The relevance of these studies 
to.the human situation is unclear as Walter et al 
(1980). have recently shown that the rat erythrocyte 
is not a good model for human erythrocyte age related 
surface changes.. 
5: Deformability 
;me 8 pm diameter erythrocyte undergoes marked 
deformation to pass through 2-3 pm diameter 
capillaries or the 0.5 to 1 pm interendothelial 
slits of the spleen. Erythrocyte deformability is 
determined by three major factors:' the cell's 
surface-area to volume ratio, the viscosity of the 
cell contents (essentially a haemoglobin solution) 
and the intrinsic membrane deformability (Weed 1970). 
The contribution of membrane deformability to 
erythrocyte deformability in ATP depleted 
erythrocytes and in hereditary spherocytosis, thought 
to be important by Weed and co-workers (see for 
example Weed et al 1969) has recently been questioned 
16. 
(Meiselman et al 1978; Nakashima and Beutler 1979). 
Whilst there is excellent evidence that reduced 
deforinability is responsible for splenic 
sequestration and reduced. red cell survival in many 
erythrocyte disorders (reviewed by Mohandas et al 
1979), it has yet to be shown whether decreased 
deformability plays a role in the destruction of aged 
normal erythrocytes. These have been shown to be less 
deformable (La Celle and Arkin 1970; Shiga et al 
1979), presumably due to their decreased surface area 
to volume ratio and increased mean cell haemoglobin 
concentration. 
The above five hypotheses are-not mutually exclusive and 
the processes described may well. interact to bring about 
the eventual destruction of the erythrocyte. 
Various., authors have studied the effects of incubating 
erythrocytes. in vitro without glucose "in vitro ageing". 
A variety of morphological andmetabolic changes occur. 
These.include a reduction of ATP.(Weed et al 1969), 
echinocytosis followed by microvesiculation (Weed et al 
1969; Lutz. et al 1977), increased intracellular Ca 
(Lichtman and Weed 1972) with resultant KC1 and water loss 
(Clark et al 1981), attacbnient.to cytoplasmic proteins to 
the membrane. (Sears et al 1975; Allen et al 1977; Allen 
and Cadman. 1979), proteolysis of synedin. (Siegel et al 
1980), alterations in spectrin organisation (Coetzer and 
Zail. 1979; Liu and Palek 1979), alterations in spectrin 
phosphorylation (Liu and Palek 1979), alterations in 
spectrin extractability (Synder. et al 1979; Lux et al 
1978), polyphosphoinositide breakdown (Muller et al 1981) 
and.a decrease in erythrocyte.deformability. It is 
relevant here to note here that the deformability decrease 
is due to the reduction of cell surface area to volume 
ratio and increased intracellular viscosity (Clark et al 
1981) and not to increased membrane rigidity as 
17. 
originally reported by Weed et al (1969). Also reports 
of glycopeptide release by endogenous protease(s) have been 
shown to be due to white cell and platelet contamination 
(Bocci 1981). 
The complex interrelationship of the above changes has 
been discussed by many authors (e.g. Allan and Michell 
1979; Liu and Palek 1979). In particular the mechanism 
of.. microvesiculation has been examined. The spectrin-free 
microvesicles released. during in vitro ageing are 
substantially similar in composition and morphology to 
those. released by Ca and ionophore (Allan and Michell 
1979; Muller.et al 1981) and .it is reasonable to suppose 
that they arise.by a common process. 
It. was hypothesised (Allen et al 1976; Allan and Michell 
1979) that Ca ++ induced vesiculation occurs as the result 
of activation of a Ca ++ dependent endogenous membrane 
bound phosphodiesterase.which breaks down 
polyphosphoinositides to inositol phosphates and 
1,2-diacylglycerol(1,2-DG), amolecule which has fusogenic 
potential. However recent work by the same author (Allan 
and Thomas l98la) has shown that accumulation of 1,2-DG is 
not necessary for microvesiculation to occur. Rather the 
minimal requirements for vesicle release are 
polyphosphoinositide. breakdown, .KC1 efflux leading to cell 
shrinkage, and increased cytosolic. Ca. In addition, in 
ATP depleted.erythrocytes. the breakdown of 
polyphosphoinositides and the.concommitant production of 
1,2-DG appear to be independent of added Ca and can 
proceed in the presence of lOmMEDTA. (Muller et al 1981). 
Currently the possibility is being examined that direct 
physical. interaction of Ca with negatively charged membrane 
phospholipids is involved in microvesiculation (Allan and 
Thomas 1981b). 
18. 
The above studies indicate how the erythrocyte can behave 
under conditions of metabolic depletion and increased 
intracellular Ca levels but it has yet to be 
demonstrated-that the processesobserved in vitro actually 
occur in vivo. 
1.6 	A BRIEF SURVEY OF ERYTHROCYTE ABNORMALITIES 	19. 
Factors giving rise to erythrocyte abnormalities can 
be inherited or acquired, intrinsic (i.e. within the 
red cell) or extrinsic. For example 
haeinoglobinopathies. are inherited intrinsic defects 
whilst acanthocytosis is an inherited extrinsic 
disorder (the primary defect being in low density 
lipoproteins). Acquired. defects can also be intrinsic 
e.g. paroxysmal nocturnal haemoglobinurea, or extrinsic 
e.g. prosthetic. heart valves can damage erythrocytes. 
(See Wintrobe 1974, Chapter 20 for a full 
classification of erythrocyte abnormalities). It has 
a1sobecome clear that abnormal erythrocytes can reflect 
systemic. molecular defects. Erythrocytes from 
Duchenne muscular. dystrophy patients are abnormal 
(Roses et.al .1975). This raises the .possibility of 
determining the molecular cause of such a disease by 
studying the convenient erythrocyte rather than tissue 
biopsies. 
The intrinsic inherited defects.have been the most 
studied. These disorders are generally divided into 
those affecting the erythrocyte membrane, the 
glycolytic pathway, glutathione metabolism, the 
haemoglobin. molecule and. miscellaneous enzymes. In some 
cases the defective molecule has.been quickly identified. 
The. spectriri of hereditary pyropoikilocytosis was shown 
to be abnormal.. within 5 years. of the first reports of 
the disease 	(Lux 1979b), whilst in conditions such 
as hereditary spherocytosis the primary defect remains 
obscure though the disease has been documented for over 
100 years. 	This. may reflect the fact the subtle 
molecular changes can be of great significance to 
erythrocyte viability, as in the haemoglobinapathies, 
whilst overt differences such as lack of glycophorin, 
20. 
the major erythrocyte sialoglycoprotein, have little or 
no effect (Anstee et al 1977). 
1.7 	HEREDITARY SPEEROCYTOSIS 	 21. 
Hereditary spherocytosis (ES). is a congenital 
haemolytic anaemia characterised by the presence of 
abnormally shaped "spherical" (actually 
spherostomatocytic) erythrocytes and increased 
erythrocyte osmotic fragility. First reported over a 
hundred years ago the clinical and cellular aspects of 
the disease are fairly well understood (Dacie 1960; 
Young 1971; Wintrobe 1974, Chapter 21) but the 
molecular basis remains. "a continuing enigma" 
(Valentine 1977). 
The condition is. inherited as an autosomal dominant 
trait with low penetrance (Race 1942), and a recent 
report suggests. that the "Es gene" is located on or 
near the. short arm of chromosome 8 or 12 (Kimberling 
et al 1978). ES is the commonest hereditary 
haemolytic anaemia in peoples of Northern European 
origin affecting approximately 1 in 5000 (Norton et 
al 1962) though Godal and Refsum (1979) suggest.: that 
the frequency may be higher due to synomless 
individuals. As. symptomatic individuals can now be 
effectively treated by splenectomy the incidence of 
the disorder is likely to increase, given a steady 
mutation rate (Dacie 1960). The intrinsic nature of 
ES was illustrated by Dacie. and Mollison (1943) who 
showed that ES erythrocyte survival, is short in ndrmal 
individuals whilst normal erythrocytes survive normally 
in ES patients. The. defect probably,. becomes manifest 
during erythropoiesis (Stefanelli et al 1980) and has 
not been shown. to affect other cell types, although the 
possibility that the condition reflects a systemic 
membrane defect has received attention (McCann and 
Jacob 1976). 
22. 
Clinically the disease is variable both in age of 
onset and severity. Anaemia, splenomegaly and jaundice 
may or may not be apparent and- there there is a wide range 
in the degree of increased.osmotic fragility and 
spherocytosis. (For a detailed discussion of clinical 
features see Dacie 1960; Wintrobe..1974, Chapter 21). 
It is. not clear whether this spectrum reflects 
heterogeneity of the underlying mutation, as for example 
in erythrocyte pyruvate.kinase deficiency, or whether 
the variation arises from.the interaction of a 
homogenous defect.with a particular individual's genotype. 
It seems.likely that.both factors..will operate. 
Certainly a homogenous defect can give rise to a 
variable disease,. e.g. sickle cell anaemia (homozygous) 
is a variable condition although the primary defect is 
always a B6 glu-val substitution, in the haemoglobin 
molecule. Wiley (1970) has indicated that the 
efficiency of. the spleen in destroying the abnormal US 
erythrocyte is variable. Factors such as this may 
explain the general observation that family members 
(who presumably have the same mutation) can be 
variously affected. Related individuals can also 
display similar erythrocyte perameters e.g. osmotic 
fragility and sodium permeability, but as yet there is 
no clear evidence of heterogeneity of. the ES mutation. 
Some of the pathogenisis of HS.can.be explained by the 
cell's abnormal shape (1), membrane permeability (2), 
and tendency to fragment (3). 
1: US. erythrocytes are not truly spherical as the name 
suggests, but exhibit varying degrees of increased 
thickness i.e. for a given volume cell diameter is 
decreased and cell breadth (thickness) is decreased. 
I 
23. 
The reticulocytes are disc-like though thicker 
than normal and. it is surmised-that as the cells age 
they become progressively spherostomatocytic. (See 
Figure 3.5 and Bessis 1976 for illustration). 
This tendency to sphericity has important 
consequences for the cell's survival: the resultant 
decrease in surface area. to volume ratio renders 
the spherocyte less deformable and therefore less 
able to negotiate the. microcirculation, especially 
in the spleen, and makes it more susceptible to 
osmotic lysis. Whether the osmotic fragility of HS 
erythrocytes contributes to their destruction in 
vivo has not been demonstrated but scanning 
electron micrographs of.HS spleens (Barnhart and 
Lusher 1976) illustrate.splenic trapping as well as 
a wrinkled and sometimes. pitted appearance of the 
erythrocyte surface which may be specific to ES. 
2: ES erythrocytes have an increased Na+ influx which 
is. balanced by a concommitant increase in the rate 
of Na+ extrusion. (Harris and Prankerd 1953; 
Jacob and Jandl 1964). The increased Na+  extrusion 
appears to be due to. an. increase, in. the number of 
cation pumps (Wiley 1972, 1977) which allow the 
cell, to maintain normal. intracellular Na+ 
concentration. Early work (Jacob and Jandi 1964) 
found.passive K+ permeability to.be normal, but 
more recently it has been found. to be increased, 
explaining the low K+  content of ES erythrocytes. 
(Kitao et al 1976; Wiley 1977). This deficit of 
total monovalent cation is reflected in the low 
water content and high mean cell haemoglobin 
concentration of ES cells. 
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3: When metabolically (Reed and Swisher 1966; 
Langley and Axell 1968; Cooper and Jandi 1969; 
Snyder et al 1978) or directly (Smith et al 1975) 
stressed, ES erythrocytes shed.membrane components 
more readily than normal.. The released material 
has a lipid composition similar to. that of the 
plasma membrane and is probably similar in 
composition to the vesicles released by normal 
erythrocytes when metabolically stressed (Snyder 
et al 1978). This loss does not, drastically alter 
the composition of the ES plasma membrane, but 
leads. to a further decrease in the cell's surface 
area. to volume ratio. 
These three aspects of the disease together with the 
pathology .of the ES spleen (it is engorged with 
erythrocytes but otherwise normal) have given rise to 
the following concept of the disease. Due to the 
reduced surface area to volume ratio of the ES 
erythrocyte the cell is relatively undeformable and 
liable to be trapped in the microvasculature of the 
spleen. The sequestered cells become deprived of 
glucose and exposed to acid conditions by the metabolism 
of adjacent erythrocytes. Lack of. glucose results in 
metabolic depletion (enhanced by the binding of ATP to 
deoxyhaemoglobin). which leads to loss of surface area. 
Acidity also increases ES erythrocyte.rigidity (Murphy 
1967), and the cells are particularly susceptible to 
metabolic depletion due to the supranormal rate of 
glycolysis needed to maintain normal intracellular 
cation concentrations. 	Some HS cells, presumably the 
less spherical young ones, will. suffer only loss of 
surface area before escaping from. the spleen and will 
recover at least partially .any ion imbalance and loss 
of ATP once in the glucose rich circulating plasma. 
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Eventually though, metabolic depletion will result in 
cell damage that predisposes the cell.to phagocytosis 
by splenic macrophages. The role of the spleen in 
the premature destruction of ES erythrocytes is 
illustrated.by an increase in lifespan from around 
20 dayspre-splenectomy (Eernisse and. Van Rood 1961) 
to around 90 days post-splenectomy (Chapman 1968). 
In spite of intense research over the last twenty years 
the primary molecular alteration in ES remains obscure. 
Investigations into US are. characterised by 
disagreement between laboratories which. may reflect the 
failure to take the variable clinical status of ES 
individuals into account as well as diversity of 
experimental method. Attention has. been focussed on 
the following areas: (1) Carbohydrate metabolism, 
(2) Membrane lipid composition, (3) Membrane protein 
composition, (4) Membrane sodium permeability and, more 
recently, (5) Cytoskeletal components, (6)Phosphorylation 
of membrane proteins and. (7) Calcium metabolism. 
1: Carbohydrate Metabolism 
There appears to be no gross defect in HS 
glycolytic and hexose rnonophosphate shunt 
enzymes (Jacob and Jandl 1964; Mohler 1965; Reed 
and Young 1967) though subtle alterations cannot 
be excluded on the available evidence. A report of 
aldolase deficiency in US (Chapman 1969) has not 
been.substantiated (Hanes et al 1970) and these 
authors question the idea of defective glycolytic or 
shunt enzymes. in.HS. as all other such enzyme 
deficiencies give rise to non-spherocytic haemolytic 
anaemia. However ES energy metabolism - is altered. 
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The overall rate of glycolysis is increased, mainly 
due to the increased activity of the sodium pump 
(Jacob. and Jandi 1964; Mohler-1965), and this is 
associated with a decrease in both the percentage 
and.absolute quantity of glucose .metabolised by the 
hexose monophosphate shunt. 
2: Membrane Lipid Composition 
It is generally agreed that there is no striking 
alteration in HS lipid composition (de Gier et al 
1964; Reed and. Swisher 1966; Cooper and Jandi 1969) 
though pre-splenectomy the amount of lipid per cell 
is less than normal in spite of the young cell 
population. Post-splenectomy lipid content returns 
to. normal, but. is deficient when compared with 
splenectomised non HS patients. Johnsson (1978) 
reported the ratio of lipid phosphorus to 
cholesterol to be slightly decreased pre-splenectomy, 
returning to norinal.post-splenectomy. Such changes 
were also seen in autoimmune.spherocytes and stored 
blood containing spherocytes. Kuiper and Livne 
(.1972) found a decrease or even disappearance of 
fatty acid chains greater than twenty carbon atoms 
long in the sphingomyelin, lecithin and 
phosphatidylserine fractions of HS erythrocytes, and 
relate this finding to the increased erythrocyte 
osmotic fragility (Livne et.al 1973) and increased 
membrane microviscosity (Aloni et al 1975). However 
Zail and Pickering (1979). could not. confirm this lack. 
Furthermore Zail. and van den Hoek found lipid 
asymmetry to be normal in HS (1975) and showed normal 
topography of phosphatidylserine and 
phosphatidylethanolaxnine by .difluro4initrobenzene 
nearest neighbour frequencies (Zail 1977). 
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Phospholipid turnover in ES . has been reported normal 
(Robertson and Lands 1964) though Jacob and 
Karnovsky (1967) found 32Pi incorporation into 
membrane phospholipids to be. twice normal. The 
specific activity in the phosphatidylserine fraction 
was increased, possibly relating to the association 
of high phosphatidylserine labelling with high sodium 
flux. Recently Etienne et al (1979) have reported an 
increased lipase activity in ES erythrocytes. 
3:. Membrane Protein Composition 
With the development of gel electrophoresis, the 
polypeptide composition of ES membranes has been 
compared with normal. Early studies were 
inconclusive (Zail and Houbert 1968; Limber et al 
1970; Gomperts et al 1972) followed by two reports 
from Japan. (Nozawa et al 1974; Hayashi et al 1974) of 
a deficiency of band 4.2 and another, Kitao et al 
(1973) reporting no difference. The current view is 
that. there is no specific protein abnormality at the 
level of one-dimensional Comassie.blue stained SDS-PAGE, 
though. cytoplasmic components may show increased 
membrane association .not specific to ES (Allen et al 
1977; Thompson and Maddy 19834. 
4: Membrane Sodium.-Permeability 
As discussed earlier in this section sodium and 
potassium equilibrium is disturbed in ES., increased 
passive fluxes of these ions being to a certain extent 
balanced by supra-normal. rates of cation pumping. 
Permeability is not altered by splenectomy. It is 
clear that the ES mutation affects some aspect(s) of 
membrane structure involved in regulating monovalent 
cation permeability. Kitao et al (1970) have reported 
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that the US cation channel is less sensitive to 
parachloroxnercuriphenylsulfonate than normal and 
suggested that the concentration,. availability or 
reactivity of SB groups may be disturbed in ES 
erythrocytes. The increased fluxes are not regarded 
as the primary US defect as their magnitude does not 
correlate with the rate of haemolysis in vivo (Wiley 
1970). 
Cytoskeletal Components 
Due to the abnormal.shape and friability of ES 
erythrocytes it is considered likely that the cells 
will have.an abnormal cytoskeleton. (Lux 1979b). 
An indication.of such an abnormality was first given 
by Jacob et al (1971) who' found that proteins 
extracted from ES. membrane aggregated less than normal 
in. the presence of cations or vinblastine. This 
finding has been questioned.. (Zail 1977). However 
various approaches have indicated that the ES 
cytoskeleton is abnormal but the component(s) 
responsible has not been determined (reviewed by 
Zail 1977; Lux 1979b). 
Membrane Protein Phosphorylation 
There have been many conflicting reports of membrane 
protein .phosphor.ylation in ES.. Greenquist and 
Shohet (1974, 1976) and Matsumoto et al (1977), report 
decreased phosphorylation in ES and heat-sphered 
erythrocyte ghosts, but this is not substantiated by 
others (Beutler et al 1976; Wolfe and Lux 1976, 1978; 
Boivin and Galand 1977). Beutler et al (.1976) 
criticised Greenquist's assay and found protein 
kinase activity to be normal when assayed in five 
minute incubations. They further pointed out that 
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a variable decrease in average phosphorylation 
after 60 minutes was seen in other.erythrocyte 
abnormalities.. Woolfe.and Lux (1978) found normal 
phosphorylation in intact ES erythrocytes and 
questioned the-physiological relevance, of ghost. studies. 
However reports of abnormal.phosphorylation in ES 
continue. For example, Moret et al (1977) found the 
ratio of..phosphorylated. serine; theonine residues to 
be abnormal in acid hydrolasts of HS erythrocyte 
membranes.. Nakao et al (1980) recently reported 
elevated phosphorylation.of band-2 in ES. Work in 
this laboratory. (Thompson and Maddy 1981a, b) has 
shown that when intact.erythrocytes are labelled with 
radioactive, phosphate,. phosphorylation of band 2 is 
depressed by about 70% relative to band 2.1 in ES 
patients prior to splenectomy. This effect was not 
seen post-splenectomy and could be mimicked by the 
introduction of calcium into normal cells. 
Furthermore, analysis. of band 2-by controlled 
proteolysis revealed no abnormality in the digestion 
pattern or sites of phosphorylation. Thus it appears 
likely that abnormal phosphorylation is not the 
primary defect in ES and, as spherostomatocytes 
persist after splenectomy (Schilling 1976), that the 
abnormal shape of US erythrocytes. is not a direct 
consequence of abnormal membrane phosphorylation. 
7: Calcium Metabolism 
in. view of the detrimental .effects of intracellular 
calcium (discussed by Lux. 1979b) calcium metabolism 
has received attention. Feig and co-workers report a 
deficiency of (Mg + Ca) ATPase in ES (1974) and 
a calcium. content of about twice normal (1976). 
Kirkpatrick et al (1975) find a lack of the high 
++ 
affinity Ca tof spectrin extracts in ES. However 
Zail and van den Hoek (1976) find no abnormality of 
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calcium content, permeability, (Mg + Ca) ATPase 
activity or calcium dependant membrane 
phosphorylation. Thus at present the situation is 
unclear. 
1.8 CONSIDERATIONS AND PROBLEMS IN THE STUDY 	 31. 
OF ABNORMAL ERYTHROCYTES. 
Patient Availability 
Most erythrocyte abnormalities are rare. The 
frequency of hereditary spherocytosis is 
approximately 200 per million and therefore an 
average city haematology department will be in 
contact with 50 or so individuals. Of these a good 
proportion will be unsuitable e.g. very young or 
very old, or unwilling to donate blood, leaving 
around 25 individuals for study. Patient 
availability thus restricts research. 
Ethical Limitations 
Many experimental approaches e.g. in vivo isotope 
studies are not ethically justifiable. Often 
indirect evidence has to be used. There are 
sometimes animal models for human conditions but, 
whilst interesting in their own right, their 
molecular basis is often different. For example 
several mutants of the common house mouse show 
inherited spherocytic haemolytic anaemia but unlike 
human HS their erythrocytes are markedly deficient 
in spectrin (Greenquist et al 1978; Lux 1979b). 
Storage of Blood Samples 
Once removed from the circulation erythrocytes begin 
to deteriorate. This deterioration can be more 
marked in abnormal states and thus when comparing 
normal with abnormal it is necessary to use samples 
immediately or within a few hours of collection. 
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Coupled with small patient numbers this factor 
severely curtails the use of sizeable samples in 
comparative studies. 
Altered Cell Behaviour 
Experimental design must take. into account any altered 
behaviour of abnormal erythrocytes.. Pathological 
samples may be damaged by procedures unharmful to 
normal red cells or may pack closer on centrifugation 
so that results cannot be expressed in terms of packed 
cell, volume etc. 
Non-Specific Alterations 
If a defect leads to decreased erythrocyte lifespan 
there is usually a compensatory increase in 
erythrocyte production. Thus the decrease in mean 
erythrocyte age.must be allowed, for in comparison 
with normal. If production is markedly increased, 
changes in marrow organization occur such that 
reticulocytes are released. prematurely into the 
circulation (Hillman 1969). These "shift" or "stress" 
reticulocytes are immature and not equivalent to 
normal circulatory reticulocytes and there is 
evidence in the rat that the erythrocytes derived from 
them are abnormal (Walter et al 1978). An idea is 
arising that a defect may be compensated for during 
erythrocyte production. Wiley (1977) has suggested 
that the increased number of sodium pumps in 
hereditary stomatocytosis and HS may be the result of 
an increased erythroblast sodium content inducing pump 
synthesis. Alternatively abnormal membrane 
degradation during reticulocyte maturation may "spare" 
the pumps. Beutler (1977) has reported elevated 
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glutathione perbxidase activity in glucose-6-phosphate 
dehydrogenase deficient erythrocytes and has 
speculated that increased levels of peroxide in 
the developing erythroblast may induce glutathione 
peroxidase synthesis.. Compensatory synthesis of 
sodium pumps has been observed in kidney (Katz and 
Epstein 1967) and He La cells (Boardman et al 1974). 
This "compensatory synthesis" hypothesis is yet to be 
proven, but may become of value in.understanding the 
relationship of abnormalities observed in defective 
erythrocytes. 
6: Choice of Control Samples 
The three factors just discussed i.e. decreased 
erythrocyte age, stress reticulocytes and 
hypothetical compensatory synthesis complicate 
the choice of control samples when attempting to 
define a specific abnormality. 
Normal blood can be used if a defect does not 
significantly alter erythrocyte lifespan. 
Correction for cell volume, surface area, 
haemoglobin content etc., may be necessary. 
High reticulocyte samples to some extent allow 
for decreased-erythrocyte age, though the 
cause of the reticulocytosis may complicate 
the issue. 
If compensatory synthesis does occur it may be 
hard. to find adequate controls, though similar 
- conditions e.g. hereditary stomatocytosis and 
HS could be compared. 
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One approach to the problem is to age fractionate 
the abnormal erythrocyte population. Coupled to 
age fractionation of normal-blood, erythrocytes of 
similar age can be compared without resorting to the 
use of abnormal controls.. This technique may also 
demonstrate.differences obscured by assay of the total 
erythrocyte-population and yields information about 
the in vivo ageing of.the defective cell, 
information..which can only be surmised. from indirect 
studies. 
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2.1 	INTRODUCTION 	 36. 
The fractionation of a population of erythrocytes 
according to age allows a direct study of the 
senescence of erythrocytes in health and disease and of 
the limiting factors in red cell survival. Age 
fractionation has been achieved with varying degrees of 
success by exploiting age related alterations in the 
cell's surface (Gear 1977; Walter 1977), osmotic 
fragility (Marks and Johnson 1958) and density (Danon 
and Marikovsky 1964; Leif and Vinograd 1964; Nakashima 
et at 1973; Corash et al 1974; Turner et al 1974). 
A universally acceptable, simple, rapid method has, 
however, yet to be found. Differential osmotic lysis 
leaves only young cells intact and the methods relying 
on surface changes are relatively complex. Of the 
density techniques, bovine serum albumin (Leif and 
Vinograd 1964), Stractan II (Corash et al 1974) and 
phthalate esters (Danon and Marikovsky 1964; Nakashima 
et al 1973)are perhaps the most suitable materials that 
have been used to construct density gradients, whilst 
erythrocytes have been fractionated by centrifugation 
in their own plasma by Murphy (1973). Each of these 
methods has disadvantages: serum albumin is expensive, 
commercially available Stractan is unacceptably crude, 
phthalate esters damage the cells and the Murphy method, 
although it is the gentlest of techniques, cannot be 
directly applied to pathological samples where differences 
in density are accompanied by significant differences 
in shape and flexibility. Also, these techniques, apart 
from those employing phthalate esters, require prolonged 
centrifugation which besides being time consuming may 
especially damage delicate pathological samples. 
At the inception of this study a new density gradient 
medium, a polyvinylpyrrolidone-coated s-ilica "Percoll" 
became commercially available. The low osmolarity, 
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viscosity, toxicity (polyvinylpyrrolidone is used as 
a blood, expander) and density range of Percoll suggested 
that it would be a suitable medium in which to age 
fractionate. both normal and abnormal erythrocytes, and 
as described in this chapter a simple, rapid and 
gentle age fractionation method was established. 
2.2 	METHODS 	 38. 
Preparation of erythrocyte suspensions. Blood was 
obtained by venepuncture from healthy male and 
female adults. Lithium heparin was used as 
anticoagulant. White cells and platelets were 
removed by a slight, modification of Beutler's (1976) 
method by passing the blood through an 
cellulose microcrystalline cellulose (2:1 w/w) 
coluxnn.in Hepes buffered.isotonic saline. (133 mm 
NaCl, 4.5 mM. KC1, 10mM Hepes, pH to 7.4 with NaOE, 
(Buffer A). The haematrocrit of the filtered blood 
was adjusted to approximately 30% and the absence of 
white cells checked by phase microscopy. This 
suspension of erythrocytes in diluted.plasma was used 
for age fractionation. When the cells were required 
for purposes other than age fractionation they were 
washed 3 times with 20 volumes of buffer A just 
before use. Blood was filtered within 2 hours of 
collection and fractionated within 4 hours of 
filtration. The reticulocyte count and density 
distribution of the filtered blood were identical to 
that. of whole blood confirming Beutler's report that 
no selective loss of erythrocytes occurs during 
filtration. 
Erythrocyte age fractionation... This is described 
fully in Section 2.3C. 
Measurement of erythrocyte distribution on Percoll 
density gradients. The distribution of erythrocytes 
after centrifugation on Percoll density gradients was 
determined by separating the gradient into fractions 
of equal volume and then calculating the percentage 
• of cells in each fraction. This was done initially by 
counting the cells on a Coulter model S. Latterly, 
the distribution was obtained by measuring the 
39. 
haemoglobin content of each fraction which, as 
erythrocyte haemoglobin content does not vary with 
age (Prentice and Bishop 1965;. Piomelli et al 1967; 
Lief 1970), is directly proportional to cell number. 
This procedure is both quicker and more accurate. 
d:. Reticulocyte counts were obtained by counting at 
least 1000. cells on films of cells stained 
"supravitallyt' (Bessis 1976) with New methylene blue 
(Dacie and Lewis 1975, p80). Prior to staining the 
washed. fractionated erythrocytes were suspended in 5% 
BSA to aid spreading of the film. 
Mean cell. volume and mean.cell. haemoglobin 
concentration were determined by standard 
haematological procedures-using a Coulter model S. 
Haemoglobin was measured. by its Soret band 
ckpk1.2 
absorbtion at 410 nm.& This procedure was found to be 
more sensitive and accurate than the 
cyarimethaemoglobin method as described by Dacie and 
Lewis (1975, pp32-34)., and enabled measurement of 
haemoglobin on the samples actually used for assay 
of enzyme and electrolyte. 
g:. Assay of erythrocyte enzymes, pyruvate kinase and 
acetylcholinesterase. Eaemolysates were prepared by 
lysing washed erythrocytes with sufficient 10 mM 
sodium phosphate buffer-pH 7.2 (buffer B) to give a 
haemolysate of approximately 1.5 g/dl haemoglobin. 
These were stored at -20 0  C until required (up to 3 
weeks), then appropriately diluted with buffer B for 
assay. Freezing did not significantly alter the 
activity of either enzyme. Each haemolysate was 
assayed in duplicate and the results expressed in 
International Units (I.U.) as defined by Beutler (1971), 
mM substrate converted per minute per gram 
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haemoglobin at 37°C. The duplicates often gave 
identical results and rarely differed by more than 5%. 
Pyruvate kinase was assayed at 37°C 
spectrophotometrically by a slight modification of 
Beutiel~s (1971) method. The assay system contained 
(final concentrations) 0.2 mM NADE, 0.4 mM AT?, 5 mM 
PEP, 6 U/mi lactate dehydrogenase (Sigma, type Xl), 
10. mM KC1, 10 mM MgCl 2 and haemoiysate of approximately 
0.3 mg/ml haemoglobin in a 0..1 M Tris-HC1 buffer. 
The final pH of the system was 7.5. 
Acetylcholinesterase was determined by the Eliman 
method (1961). The assay system contained (final 
concentrations) 0.0765 mM dithiobisdinitrobenzoic 
acid, 0.5 mM acetyithiocholine and haemolysate of 
approximately 0.05 mg/mi haemoglobin in a 0.1 M 
sodium phosphate buffer. The final pH of the system 
was 7.4. 
h: Erythrocyte potassium content was measured by flame 
photometry. The cells were rapidly washed free of 
buffer A by 2 washes of isotonic sucrose (2.5 minutes 
at 1000 x g, 10 ml isotonic sucrose per 0.1 ml packed 
cells) and. lysed with glass distilled water. The 
lysates were stored at -20 
0
C.untii required then 
dilutedto approximately 1.6 mg/di haemoglobin with 
glass distilled water containing .4 mg/i Triton X-100 
prior, to potassium determination. The results were 
expressed as uNeK /g haemoglobin. Each sample was 
measured in duplicate. Duplicates usually varied by 
less than 5%. 
2.3 DEVELOPMENT OF THE AGE FRACTIONATION SYSTEM 	41. 
a: Choice and Preparation of Media. 
Effort was made to form Percoll density gradients in 
- 	as near physiological conditions as practicable. The 
most physiological medium possible, made by the 
addition of 760mg/mi freeze dried human plasma to 
Percoll, was found to be unsuitable due to problems of 
pH control and the presence of divalent cations which 
encourage clumping. Batch variation and hepatitis 
risk were also contraindications. A more successful 
approach was to adjust tonicity with physiological 
levels of sodium and potassium chloride and to make 
the protein concentration physiological with bovine 
serum albumin (BSA) (human serum albumin being 
harder to obtain and carrying hepatitis risk). The 
BSA.. was found to aid in the maintenance of normal cell 
morphology and to visibly reduce clumping. (Compare 
Figure 1 with Alderman et. al 1980). It also increases 
the density of the medium, a factor which is important 
in the fractionation of abnormally dense 
erythrocytes. Hepes was chosen-as buffer rather than 
phosphate to allow subsequent use of fractionated 
erythrocytes in experiments involving 32P labelling 
and divalent cation without change of buffer. 
The density gradient solutions were prepared as 
follows: 
"Physiological" BSA. A 5.263% solution of BSA 
(Cohn fraction V 1 Sigma) was made in distilled water 
and brought to pH 7.4 with NaOH. (IN NaOH was added 
dropwise to a vigorously stirring solution. No 
denaturation was apparent). This solution was then 
made isotonic and 5% in BSA by the addition of 1 
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volume of 20x concentrated buffer A to 19 volumes 
of the BSA solution. 
"Physiological" Percoll. This was made in a similar 
manner except for the adjustment of pH. A 5.263% 
solution ofBSA in Percoll could not be brought to 
pH 7.4 with iN NaOH as a flaky white precipitate 
formed on addition on the NaOH. Therefore, the pH 
of the 20x concentrated buffer A was adjusted to give 
the final. solution (isotonic BSA Percoll) apH of 
7.4. Due to variation in the acidity of the BSA, the 
pH of the 20x concentrated. buffer A had to be 
adjusted for each batch of BSA and varied between 
8.5 and 9.2. The required. pH.was determined by 
direct measurement of small, volumes of "physiological" 
Percoll. 
Buffer .A was made up as required. and stored at 4 
0C 
for up to a week. The other solutions were made up 
on the day of use, or could be stored at -20°C with 
no ill effect. "Physiological" Percoll was found to 
be unstable at .4 0C after a few days. 
Choice and Preparation of Density Gradients 
Continuous linear density gradients were found to be 
superior to step gradients due to 'padding' of 
erythrocytes at step interfaces, a view vehemently 
substantiated by Lief (1979). If single fractions 
from continuous gradients were re-centrifuged on 
fresh gradients they formed a narrow distribution 
centred around the predicted density. Fractions from 
step gradients however showed. poor rebanding. 
To minimise the exposure of erythrocytes to the 
density gradient medium and centrifugation, the 
gradients were preformed as required from equal 43. 
volumes of appropriate mixtures of "physiological" BSA 
and "physiological" Percoll using a gradient mixer 
attached to a peristaltic pump. The linearity of the 
gradients so formed was initially checked by the 
addition of bromphenol blue to one of the solutions 
and subsequent measurement of the absorbance at 510 nm. 
(The)max of bromophenol blue in 5% BSA is 510 run). 
Refractive index measurements also confirmed linearity. 
Due to the narrow density range of the gradients 
required to fractionate erythrocytes and the variations 
in bead density with medium, Pharmacia density marker 
beadswere of no use in either gradient checks or 
density measurement. However, the gaussian density 
distribution of normal erythrocyte populations gave a 
check of every gradient used for age fractionation. 
Gradients of either 9.5 ml (14 x 60 mm) or 36 ml (24 x 
90 mm) were made and appeared equally effective at age 
fractionation, 4x the number of cells being 
fractionated on the 36 ml gradient. 
C: The Age Fractionation Procedure 
As cell density varies between individuals (Leif and 
Vinograd 1964), gradients of broad density range 
(55 - 85% Percoll) were first run to establish the 
optimum density range for the age fractionation of a 
particular sample. This was determined by measuring 
the position of the sample on the broad gradient and 
was usually in the region of 60 - 70% Percoll. Then 
0.5 ml of erythrocyte suspension (Section 2.2a) was 
carefully layered on. top of an appropriate 9.5 ml 
gradient (or 2 ml on a 36 ml gradient) and the cell 
gradient interface broken by gentle stirring to 
prevent padding. If more, e.g. 1 ml, cells were 
loaded artefactual banding often occurred. The 
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gradient was then centrifuged at 1100 x g (r av 
16.5 cm) in a MSE Mistral 4L centrifuge with a MSE 
universal swingout head No. 62303 for five minutes 
at room temperature. (Angle rotors were found to be 
unsuitable, as the erythrocytes stick to the outer 
wall of the centrifuge tube). Deceleration was done 
without braking to prevent perturbation of the 
gradient. With the small gradients collars had to be 
fitted to the buckets to ensure swing out to 
horizontal. Incomplete swing out resulted in a 
"streak" of cells down the tube. The erythrocytes 
did not.. change their position.in the gradient if 
centrifuge time was extended, but. fractionation 
deteriorated..as the cells tended-to clump after 
longer time intervals. As clumping also appeared 
worse at 4°C, separation was performed at room 
temperature, 18 °C. 
After centrifugation, plasma which remains at the 
top of the gradient was removed and the cell fractions 
• sequentially aspirated from the top of the gradient 
using a pipette attached to a peristaltic pump, 
manoeuvered manually over the liquid surface. This 
simple collection method was found to be superior to 
the more sophisticated dropping out or displacement. 
Tubes with screw.bottoms were made to allow dropping 
• out (no disposable tubes being of suitable size, 
rigidity and cost), but variation in drop size and 
the small volumes of the fractions .made collection 
of equal volumes difficult. Displacement caused 
significant mixing of the non-viscous Percoll 
gradient. One large or small gradient could provide 
enough material for some experiments but fractions 
from. different gradients were pooled where necessary. 
The reproducability of the fractionation is good, 
enabling this to be done. Finally the erythrocytes 
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were washed 3 times with 10 ml of buffer A to remove 	- 
the Percoll gradient medium and immediately used as 
required. 
46. 
2.4 TESTS OF THE AGE FRACTIONATION. PROCEDURE 
As the most direct test of age fractionation, radioactive 
cohort labelling (Piomelli et al 1967; Leif 1970), 
cannot be readily performed with human erythrocytes, the 
effectiveness of the Percoll gradients was established by 
comparing, the distributions of erythrocytes and 
reticulocytes in the gradient-with those of other density 
systems, and by studying a selection of parameters 
reflecting different aspects of erythrocyte physiology 
which have previously been shown to alter with age. 
Mean cell volume and mean cell haemoglobin concentration 
were measured as.a reflection.of the selective loss of 
erythrocyte components during ageing. 
As mentioned in the introduction, many erythrocyte enzyme 
activities, decrease with age presumably due to such 
events as loss of material, post translational 
modification, alteration in levels of allosteric 
effectors etc. Preliminary experiments showed the 
expected declines in hexokinase,. phosphoglycerate kinase, 
pyruvate .kinase, glucose-6-phosphate dehydrogenase, 
6-phosphogluconate dehydrogenase and acetylcholinesterase 
activities. Pyruvate kinase and acetylcholinesterase 
were chosen for further study as they reflect both 
internal. (pyruvate kinase) and external 
(acetyicholinesterase) aspects of the erythrocyte, are 
well documented. in the literature and are convenient to 
assay. 
The levels (Cohen et al 1976) and distribution (Schrier 
et al 1980) of erythrocyte inorganic cations, e.g. Na+ 
~ 	+ 
K , Ca + , have been shown to alter with age. The most 
abundant of these, K+, was examined. 
47. 
a: The distribution of erythrocytes on Percoll 
density gradients. 
In common with other.workers. (for example, Leif and 
Vinograd 1964; Turner et al. 1974) a normal 
distribution, of. erythrocytes along the gradient was 
observed (Figure 2.1). Cell density was found to 
vary between individuals (See Figure 3.2 Chapter 3) 
but a healthy individual's erythrocytes maintained 
the same density for long periods of time. The mean 
density of the author's erythrocytes was 1.0978 
g/ml 20°C in 1978 and 1.0967 in 1980. As reported 
by Nakashima et al (1973) and Oda et al (1978) males 
• tend to have denser erythrocytes than females. The 
mean of the mean erythrocyte density of 9 males 
studie& was 1.099120 whilst.that.of 5 females was 
1.096844. Although these samples are small, the 
result is statistically significant, P<0.00l by 
Student's t test. 
The above mean erythrocyte densities are similar to 
those reported by Abraham et al (1975) and Cohen et 
al (1976). However there is considerable variation 
in.the literature ranging from 1.0836 (Leif 1970) to 
approximately 1.11 (Turner et al 1974). The reason 
for this is not clear though Leif performed 
fractionation at. 4 °C and Turner et al used step 
gradients. There is also variation in the reported 
density spread of erythrocyte populations. The mean 
spread found in this study, 0.012 g/ml 20°C (Table 
3.1, Chapter 3) measured as.the density range between 
-2 and +2 standard deviations from the mean density, 
i.e. the density range within which 95% of the 
population lies, is similar to the 0.014 found by 
Cohen et al (1976) using phthalate esters. 
48. 
Leif (1970) however, using continuous linear BSA 
gradients, found the 95% range of erythrocytes from 
2 individuals to be 0.0244 and 0.018. 
Because of erythrocyte density variation between 
individuals age related parameters must be expressed 
in terms of position in the density distribution 
rather than erythrocyte density to allow pooling of 
data. The position of a given fraction in the 
distribution can be expressed in two ways: 
Cumulative distribution function.or haemoglobin 
percentile (Piomelli et al 1968; Turner et al 
(1974) which is calculated as follows: 
y=x-1 
Eb X + 	y = Hb percentile of fraction x 
where Hb x and Eb-y are the haemoglobin contents 
of individual fractions expressed as a 
percentage of the total amount of haemoglobin 
applied to the gradient. i.e. the haemoglobin 
percentile gives .the. percentage of cells in the 
.gradient.of lower density than the mean density 
of the fraction in question. 
Standard-deviation-from-the-mean-density 
As the erythrocyte density distribution is normal 
this can be calculated from the haemoglobin 
percentile using probability tables (Turner et 
al 1974). 
Plotting age related parameters against these two 
different expressions of fraction position in the 
density distribution stresses different aspects 
of the data: 
49. 
Because the erythrocyte density 
distribution is normal, the haemoglobin 
percentile of density fractions does not bear 
a linear relationship to the mean density of 
the fractions. However experiments involving 
radioactive cohort labelling (Piomelli et 
al 1968; Lèif 1970) show a linear 
relationship between time and the midpoint 
of the radioactive distribution expressed as 
haemoglobin percentile. Thus a plot of an 
age related parameter against haemoglobin 
percentile shows the change in the parameter 
with respect to time. 
It follows from the linear relationship 
between haemoglobin percentile and time just 
mentioned and the normal density 
distribution, of erythrocyte populations, 
that erythrocyte density does not increase 
linearly with time. (This is discussed in 
detail by Leif 1970). Thus plotting an age 
related parameter agaijst standard 
deviation from the mean density (i.e. against 
density,. standard deviation having the same 
unit as the data it is derived from) does 
not. illustrate the change in the parameter 
with respect to time. This is not always 
appreciated (Turner et al 1974). 
Both types of plot are used in this thesis. The 
haemoglobin percentile is used to illustrate age 
related changes with respect to time. Standard 
deviation from mean density is used to allow 
comparison and analysis of data as it has been 
reported by others that age related parameters 
50. 
often show linear or exponential declines with 
respect to density (for example, Piomelli et 
al 1968; Turner et al1974; Galbraith and 
Watts 1980). 
b: The distribution of reticulocytes on Percoll 
density gradients. 
The data from 8 individuals summarised in Figure 2.2 
is consistent with an exponential fall in 
reticulocyte count throughout the gradient down 
to the threshold of the counting and procedure (0.1%). 
Extrapolating, a fraction containing 100% 
reticulocytes would be expected -4.25 standard 
deviations from the mean. Similar, results have been 
reported-by Piomelliet al. (1968) using BSA step 
gradients, Turner et al (1974), and Galbraith and 
Watts (1980) both using Ficoll - Triosil step 
gradients. These authors estimated 100% 
reticulocytes to lie -4.25,. -5.25, and -4.35 standard 
deviations from the mean respectively. 
C: Mean . cell volume (MCV) and. mean cell haemoglobin 
concentration (MCEC). 
It has long been known that mean cell volume 
decreases with erythrocyte age and, as mean cell 
haemoglobin remains constant, mean cell haemoglobin 
concentration increases with age. These parameters 
were measured in the density fractions from 10 
separate experiments. Typical results are shown in 
Figure 2.3 (MCV) and 2.4 (MCHC). The age 
fractionation procedure does not appear to alter 
either parameter as the values at the mean density 
51. 
(the point at which the erythrocytes have gone 
through half their life span) are close to those of 
unfractionated erythrocytes. The results are similar 
to those reported by Murphy (1973) and Cohen et al 
(1976) using centrifugation in plasma at 30 
0C in an 
angle rotor ("the Murphy method"). 
Erythrocyte enzyme activities. 
The expected decreases in pyruvate kinase activity 
shown in Figure 2.5 (Paglia and Valentine 1970, 
using BSA steps; Corash.et al 1974, using Stractan II 
step gradients) and acetyicholinesterase activity 
shown in Figure 2.6 (Cohen et al 1976; Kadlubowski 
and Agutter 1977, both using the Murphy method) were 
observed. Three typical experiments are illustrated. 
For further data see Figures 4.1 and 4.3, Chapter 4. 
As the activities at the mean density are similar to 
those of the total erythrocyte population the age 
fractionation procedure does not appear to affect 
either enzyme. 
Erythrocyte potassium content. 
Again a similar decrease to that reported by others 
(Cohen et al 1976) was observed (Figure 2.7). No 
effect of the fractionation. procedure on erythrocyte 
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FIGURE 2.1 	The distribution of erythrocytes after 
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FIGURE 2.2 : The distribution of reticulocytesin erythrocyte 













I 	 I 	 I 	 I 
-3 -2 -1 	0 1 	2 	3 T 
Position in gradient (S.D.) 
FIGURE 2.3 : The density related decrease in mean cell volume 
(NCV) of erythrocytes fractionated on Percoll 
density gradients. Each point is the mean of 
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FIGURE 2.4 : The density related increase in mean cell 
haemoglobin concentration (MCHC) of erythrocytes 
fractionated on Percoll density gradients. 
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FIGURE 2.5 	The correlation between increased cell density 
and decreased pyruvate kinase (P.K.) activity 
of erythrocytes fractionated on Percoll density 
gradients. Each measurement is the mean of a 
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FIGURE 2.6 	The correlation between increased cell density 
and decreased acetyicholinesterase (ACh.E.) 
activity of erythrocytes fractionated on 
Percoll density gradients. Each point is the 
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FIGURE 2.7 	The correlation between increased cell density 
and decreased potassium (K+)  content-.of 
erythrocytes fractionated on Percoll density 
gradients. Each point is the mean of a duplicate. 
Three typical experiments are shown. T, total 
erythrocyte population. 	 •: 
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2.5 DISCUSSION 
The comparison of these resultswith those of other 
workers show that Percoll density gradients are as 
effective at age fractionating erythrocyte populations 
as other methods. The Percoll method has several major 
advantages: 
The speed of attaining equilibrium (5 min as 
compared with ½ - 2 hours). 
It allows the density distribution of an 
erythrocyte population to be easily and rapidly 
determined, in particular in pathological cells 
which may not only be of abnormal shape and 
flexibility but may also be denser than normal and 
too dense to be separated on other gradient 
materials without problems of high. viscosity. 
Gradient density may be easily varied at will, the 
low viscosity of Percoll making linear gradient 
formation quick and easy. 
It is relatively inexpensive and available 
commercially in a pure sterile state. 
The simplicity and speed of the method suggests that it 
might be adopted for clinical diagnostic purposes e.g. 
to age match erythrocytes for detection of enzyme 
defects which can be obscured by the high reticulocyte 
count of such abnormal blood. The quantities of cells 
separated are sufficient to allow study of erythrocyte 
ageing in both intact cells and in ghosts. 
On a more speculative note, Piomelli et al (1978) have 
58. 
shown with 51 C labelling that the light cells 
obtained after density gradient centrifugation on 
arabino-galactose (Stractan II) survive significantly 
longer than the heavy cells when transfused back into 
the donor. They suggest, extrapolating to humans, that 
the use of young age iractionated erythrocytes for 
transfusion could significantly reduce iron overload 
in chronic transfusion therapy. The sterility, 
autoclavability and non-toxicity of Percoll indicate 
that it would be a most suitable medium in which to 
obtain young erythrocytes for such purposes, though 
obviously detailed toxicity tests would be required 
before such a procedure could be tested in humans. 
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3.1 INTRODUCTION 	 60. 
Current understanding of the pathogenesis of HS has 
been surmised from the appearance and behaviour of HS 
erythrocytes in vitro and from the histology of the HS 
spleen (Section 1.7). In spite of the obvious potential 
of age fractionation both in describing the events 
leading to the premature demise of the HS erythrocyte 
and in determining the underlying molecular defect 
(Sectionl.7 and 1.8), HS erythrocyte age fractions 
have not yet been examined, possibly due to the 
difficulties of effectively fractionating the abnormally 
dense but delicate US cells with existing density 
gradient media (Section 2.5). In this chapter it will 
be shown that Percoll. density gradients allow effective 
age fractionation of HS erythrocytes. 
3.2 METHODS 	 61. 
Preparation of erythrocyte suspensions for 
fractionation was as described in Section 2.2a. The 
cellulose filtration did not appear to damage the 
abnormal US erythrocytes. 
US erythrocytes were age fractionated as described 
in Section 2.3c. There was no evidence that the 
fragile US erythrocytes were damaged by the 
procedure. Broader gradients were required as the 
US erythrocytes are denser than normal. 
C: Erythrocyte density distributions were determined as 
described in Section 2.2c. Usually gradients were 
fractionated into 8 for distribution studies though 
6 or 16 fractions were also collected. The mean 
density and spread of each sample was estimated as 
follows: First the density range of the gradient 
used for fractionation was calculated in g/ml, 20°C, 
from. a calibration curve made by accurately weighing 
10 ml. samples of various mixtures of "physiological" 
BSA and "physiological" Percoll. Then the mean 
density and 95% range of the sample were determined 
from histograms of the density distribution plotted 
on graph paper by counting squares. (It should be 
noted that as the experimental data is not ideal 
the mean density is not always in the centre of the 
range). 
d: Osmotic fragility tests were performed as described 
by Dacie and Lewis (1975, pp  202-203) except that 
the percentage lysis was determined by measurement 
of the Soret band absorbtion (410 nm) of the various 
supernates. This enabled fragility tests to be 
performed with only a few microlitres of blood. 
62. 
e: Reticulocyte counts were performed as described in 
Section 2.2d. 
Mean cell volume and mean cell haemoglobin 
concentration were measured as described in 
Section 2.2e. 
Heinz bodies were demonstrated by supravital 
staining with Rhodanile blue as described by 
Simpson et al (1970). 
63. 
3.3 A COMPARISON OF NORMAL AND HS ERYTHROCYTE 
DENSITY DISTRIBUTIONS. 
When ES erythrocytes were centrifuged on Percoll density 
gradients it was immediately obvious that they were 
denser than normal. Figure 3.1 shows typical density 
distributions of normal and ES erythrocytes, pre and post-
splenectomy. In Figure 3.2 the mean densities and 95% 
ranges are shown for 14 normal (9 male and 5 female), 
7 ES post-splenectomy and 10 HS pre-splenectomy samples. 
Three of the ES pre-splenectomy samples were from 
children which may account for the low initial density 
observed in these cases. Due to problems of taking blood 
from healthy children, no density distributions were 
obtained for-normal children. 
These data clearly show that ES erythrocytes exhibit an 
abnormal. density profile as suggested by Nakashima et 
al (1973) and Oda et al (1978). Prior to splenectomy 
HS erythrocytes exhibit a flat but normal density 
distribution with a greater mean density and variance 
than normal blood. After splenectomy the density 
distribution reverts towards the healthy pattern but 
remains significantly denser and broader. The 
statistical significance of these results is pIesented 
in Table 3.1. The observed reversion after splenectomy 
is most probably a result of removing splenic stress 
from the fragile ES erythrocyte rather than the effect 
of splenectomy perse,  as the erythrocyte density of a 
person splenectomied. for trauma was normal (data not 
shown). This conclusion is tentative however, as only 
one normal post-splenectomy individual was examined, 
such samples being difficult to obtain. 
It is also apparent that the majority of ES 
reticulocytes are abnormally dense, indicating that 
whatever the US lesion it is manifest at the 	64. 
reticulocyte stage of erythroid differentiation. This 
has been concluded by other workers using different 
approaches (Dacie 1960; Stephanelli et al 1980). 
Full blood counts were available for some of the normal 
(Table .3.2a) and most of the US individuals (Tables 3.2b 
and c) studied, but. no striking correlation could be seen 
between red cell count, haemoglobin level, haematocrit, 
mean cell volume, mean cell haemoglobin, mean cell 
haemoglobin concentration, reticulocyte count and density. 
This is not surprising for a.nunlber of reasons: 
The number in the study is small and individual 
variation in the parameters examined is quite large 
(Dacie and Lewis 1975, pp 12-14) due to both 
technique (e.g.. reticulocyte counting is notoriously 
inaccurate, Fehr and Knob 1979) and true biological 
variation. 
Mean. cell volume, mean cell haemoglobin and mean cell 
haemoglobin concentration are average measurements 
which can obscure abnormalities. (e.g. blood 
containing both abnormally large and abnormally small 
erythrocytes may have a normal mean cell volume). 
The measurement of mean cell volume by the electronic 
counters widely used in clinical haematology 
laboratories is affected by cell shape and flexibility 
(Waterman 1975) such that the volume of round and 
flexible cells is over-estimated. Furthermore as mean 
cell volume is used to derive.haematocrit and mean cell 
haemoglobin.concentration, a falsely high volume 
measurement results in over-estimation of haematocrit 
and under-estimation of mean cell haemoglobin 
concentration. Recent work by Mohandas et al (1980) 
65. 
concluded that the Coulter S model (used in this work) 
is unlikely to give accurate red cell indices in 
conditions such as. ES where the cells are dehydrated 
with resultant high mean cell haemoglobin 
concentration and decreased deformability. This 
conclusion was drawn from the comparison of manually 
(true) and electronically derived mean cell haemoglobin 
concentration values of normal erythrocytes 
experimentally manipulated to give a wide range of mean 
cell haemoglobin concentrations: at a concentration of 
50. g/dl the Coulter S measurement was 20% low. In 
support of Mohandas et al's extrapolation to abnormal 
erythrocytes, the author noted during an attempt to 
obtain volume distributions of age fractionated ES 
erythrocytes using a channelising Coulter counter that 
the small cell spherocyte enriched fractions gave 
larger volume readings than the large cell 
reticulocyte rich fractions. 
One of the unspienectomised ES individuals, J.K., was 
clinically unaffected. It was noted with interest that 
his erythrocyte density distribution fell within the 
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FIGURE 3.1 : Typical density distributions of normal and HS 
erythrocytes pre and post-splenectomy. The data 
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FIGURE 3.2 : The density (mean and 95% range) of erythrocytes 
from. normal and HS individuals pre and post-
splenectomy. 
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DENSITY (g/ml. 200C) 95% RANGE (g/ml, 20°C) 
SAMPLE MEAN + STANDARD DEVIATION MEAN + STANDARD DEVIATION 
NORMALS 
n 	14 1.098310 + 0.001439 0.012015 + 0.002286 
ES POST SPLENECTOMY 
= 	7 1.105419 + 0.000949 0.017553 + 0.001892 
ES PRE SPLENECTOMY 
10 1.110105 + 0.003608 0.032540 + 0.004982 
t TEST BETWEEN 
NORMAL AND MS 
POST SPENECTOMY P < 0.001 P<0.001 
NORMAL AND MS 
PRE SPLENECrOMY P ( 0.001 P <0.001 
MS POST SPLENECTOMY 
& MS PRE SPLENECTOMY 
0.001<P(0.01 P(O.001 
TABLE 3.1 	The statistical significance of the difference 
between the mean cell density and mean density 
spread (95% range) of 14 normal, 7 HS post-


























MALE 	1 1.1001 5.37 14.3 .424 79 26.1 33.7 nd 
(1.0920-1.1076) 
2 1.1006 5.26 15.5 .150 135 29.5 34.6 1.5 
(1.0940-1.1077) 
3 1.0985 4.86 14 .408 84 28.7 34.3 <1.0 
(1.0925-1.1051) 
4 1.0992 nd nd nd 89 31.1 34.1 2.0 
(1.0936-1.1047) 
5 1.0979 nd nd nd 90 31.1 34.3 1.0 
(1.0918-1.1035) 
FEMALE 	1 1.0972 ml ml ml 08 31.3 35.2 0.0 
(1.0927-1.1034) 
2 1.0970 4.72 14.4 .428 91 30.5 '3.6 1.0 
(1.0915-1.1025) 
3 1.0975 nd ml nd 91 32.5 34.7 0.6 
(1.0926-1.1025) 
TABLE 3.2a 	The density and haematological parameters of normal individuals. 

























MALE 	.1K 1.1109 3.98 13.4 .365 91 33.5 36.5 2.6 
(1.0961-1.123) 
JC 1.1134 3.70 11.5 .317 85 31.0 36.2 11.4 
(1.0968-1.1278) 
DH 1.1094 4.20 14.8 .387 92 35.2 38.3 18.1 
(1.0936-1.1255) 
JMc C 1.1110 3.79 13.6 .387 100 35.3 35.0 20.0 
(1.0895-1.1291) 
FEMALE 	EK 1.1120 4.19 12.1 .332 79 20.6 36.0 8.0 
(1.0949-1.1281) 
CR 1.1143 4.33 13.5 .370 05 31.1 36.5 35.5 
(1.1005-1.1276) 
VW 1.1137 3.63 11.8 .340 93 32.6 35. nd 
(1.1030-1.1255) 
CHILD 	MS 1.1064 3.55 10.6 .306 76 26.7 34.5 18.8 
(1.0802-1.1268) 
TS 1.1064 4.20 11.6 .338 79 27.5 34.3 10.1 
(1.0909-1.1268) 
TABLE 3.2b 	The density and haematological parameters of HS pre-splenectomy individuals. 
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MALE 	MC 1.1070 5.98 17.5 .486 81 29.3 36.1 1.0 
(1.0979-1.1151) 
CS 1.1053 5.45 16.7 .403 09 30.0 34.5 2.0 
(1.0969-1.1140) 
FC 1.1052 5.30 17.2 .487 92 32.1 34.6 1.4 
(1.0958-1.1147) 
CQ 1.104 5.13 15.5 .438 86 31.3 36.2 <1.0 
(1.0946-1.1126) 
FEMALE 	MF 1.1054 4.70 14.3 .309 81 30.2 36.9 1.9 
(1.1097-1.1121) 
AC 1.1049 nd 14.0 .390 rid rid 36 0.0 
(1.0944-1.1152) 
JC 1.1052 rid rid rid rid rid nd 0.6 
(1.0905-1.1140) 
-4 
H TABLE 3..2c 	The density and haematological parameters of HS post - splenectomy individuals. 




COUNT (%) - (WHOLE BLOOD) 
MEAN RETICULOCYTE 
COUNT (%) OF 
FRACTIONS MORE THAN 
+0.1 STANDARD 
DEVIATION 	FROM 
THE MEAN DENSITY A/B 
NORMALS 	 1 0.8 < 0.1 > 8 
2 0.8 <0.1 >8 
3 1.0 (0.1 >8 
4 1.0 <0.1 >8 
5 0.5 <0.1 >5 
6 0.5 <0.1 	. > 
HS PRE SPLENECTOMY 
C.R. 25.0 8.0 3.1 
J.C. 10.0 6.0 1.7 
E.K. 8.0 5.0 	. 1.6 
T.S. 10.0 3.6 2.8 
M.S. 8.3 3.0 2.8 
J.K. 3.5 . 	0.5 7.0 
TABLE 3.3 	A comparison of the proportion of % reticulocytes 
in whole blood to % reticulocytes in fractions 
more than +0.1 standard deviations from the mean 
density in normal and HS pre-splenectomy 
individuals. 
3..4 TESTS OF. AGE FRACTIONATION 	 73. 
The correlation of erythrocyte density and 
osmotic fragility. 
The reversion after splenectomy of ES erythrocyte 
density distributions towards the healthy pattern 
(Figures 3.1 and 3.2) parallels the well documented 
partial restoration of normal osmotic fragility after 
splenectomy (illustrated in Figure 3.3). Osmotic 
fragility curves of Percoll density gradient fractions 
of. ES erythrocytes were determined for 3 ES pre-
splenectomy and 1 ES post-splenectomy individuals. 
Typical pre-splenectomy results are shown in Figure 3.4. 
The individual density fractions have a more homogenous 
fragility than the total erythrocyte population, the 
lightest cells being the least fragile, the densest the 
most fragile. As Griggs et al (1960) have shown by 
59Fe labelling ES blood that the most fragile cells are 
the oldest cells, it therefore appears that the Percoll 
density gradients are age fractionating the abnormal 
ES erythrocytes. 
The distribution of reticulocytes and spherocytes 
on the gradient. 
It is apparent from Figure 3.5 that the ES erythrocytes 
are being fractionated into. reticulocyte rich, light, 
large cell-fractions and spherocyte enriched, dense, 
small cell fractions. The decline of reticulocyte 
count with position in the gradient is shown in 
Figure 3.6. Post-splenectomy there is an exponential 
decrease down to the threshold of the counting procedure 
(0.1% reticulocytes) with 100% reticulocytes expected 
-4.35 standard deviations from the mean. As a similar 
decline is seen in normal blood (Figure 2.2, Chapter 2) 
74. 
it is most likely that the HS erythrocytes post-
splenectomy are being age fractionated in the same 
mariner as normal erythrocytes. Pre-splenectomy 
however, more reticulocytes are seen in the bottom 
half of the. gradient than would be predicted by a 
simple increase in overall reticulocyte level 
(Table 3.3). There are a number of possible 
explanations of this observation: 
Some of the cells classed as reticulocytes are 
in fact erythrocytes containing inclusions other 
than reticulum. 
There is an increased number of dense 
reticulocytes in US blood pre-splenectomy. 
The Percoll gradients do not age fractionate US 
pre-splenectomy erythrocytes in the same manner 
as normal blood. 
1. It is difficult to distinguish between mature 
reticulocytes (i.e. reticulocytes which have lost 
most of their reticulum) and erythrocytes bearing 
inclusions such as small.. Heinz bodies (inclusions 
composed of haemoglobin degradation end products). 
(Dacie and Lewis 1975, pBl). 3% of US 
erythrocytes post-splenectomy contain Heinz 
bodies (Schilling 1976) and it is possible that 
small Heinz bodies could escape splenic 
surveillance, especially if the spleen is over -
loaded. Also the New methylene blue used to stain 
reticulocytes is a redox reagent capable of 
inducing formation of haemoglobin precipitates 
75. 
(Zinkhaxn et al 1979). Though no inclusions were 
seen in the densest fractions of normal blood 
after New methylene blue staining, aged US cells 
are likely to be more susceptible to such damage. 
The observation that the "reticulocytes" seen in 
the bottom half of the gradients are generally 
smaller than those at the top (compare Figure 3.5e 
and. f) suaqested. that they may in fact be 
erythrocytes containing small Heinz bodies. In 
support of this view,, when reticulocyte counts 
were performed on fixed counterstained 
preparations (Heinz bodies are not visible in 
these, Dacie and Lewis 1975, pBO) there appeared 
to be fewer reticulocytes in the denser fractions. 
However interpretation of.the slides was difficult 
due to the recognised problem of. precipitated 
stain.. Supravital staining with Rhodanile blue 
did not reveal, the presence of Heinz bodies in the 
dense. fractions, but the batch of dye used only 
stained large Heinz bodies weakly. 
In conclusion it seems probable.that some of the 
dense "reticulocytes" are erythrocytes containing 
small Heinz bodies but.further work is required 
to establish this. 
2. It is likely that there will be an increased number 
of. dense reticulocytes in. HS pre-splenectomy 
individuals. Firstly, in US erythropoiesis is 
markedly ineffective (Stephanelli et al 1980) i.e. 
erythrocytes are produced that are so defective 
that they are destroyed before or shortly after 
leaving the marrow. Thus there will be more 
variation than normal in the composition of 
reticulocytes some of which will be dense. 
Secondly, if there is a significant red cI 
destruction reticulocytes.are re]sed prematurely 
into the circulation i.e. "stress reticulocytes" 
(Section 1.8). As these stress reticulocytes are 
less deformable than normal (Leblond et al 1978) 
they are liable to. be trapped in the spleen where 
the hostile splenic environment may prematurely 
age the cell leading to an increase in density. 
3. Though the Percoll gradients achieve an age 
fraction of ES erythrocytes the effectiveness 
of the. procedure may differ.from normal. It is 
hard to evaluate this possibility without in vivo 
radioactive cohort labelling (which is impossible 
for. ethical reasons) as the parameters normally 
used to assess the extent of fractionation may 
themselves be altered due to the underlying 
biochemical abnormality. in ES. The greater than 
normal. density range of ES erythrocytes might be 
expected to lead to.a.more efficient fractionation. 
However any such effect may be balanOed by the 
greater variation in erythrocyte composition 
discussed in 2. 
In conclusion the distribution, of reticulocytes on 
the gradient shows that age fractionation of ES 
erythrocytes is achieved by Percoll density 
gradient centrifugation but raises the possibility 
that in pre-splenectomy samples the pattern of 
fractionation may differ from normal. 
C: Mean Cell volume and Mean Cell haemoglobin 
concentration. 
The change in these parameters with position in the 
gradient is shown .for 2 cases of ES pre-splenectomy 
77. 
(Figure 3•7;•)  and 2 cases.of HS post-splenectomy 
(Figure 3.7:'). Similar changes to normal are observed 
(compare with Figures 2.3 and 2.4) post-splenectomy 
and in one of the pre-splenectomy individuals. In the 
other greater than normal changes are observed as 
might be expected in. a population of red cells 
containing both stress reticulocytes and spherocytes. 
However as measurements of mean cell volume and mean 
cell haemoglobin concentration are unlikely to be 
accurate in HS (See Section 3.3), little significance 
can be attached to the magnitude of change. The results 
are nevertheless in agreement with the other evidence 











FIGURE 3.3 : Osmotic fragility curves of HS blood showing 
incomplete reversion towards normal fragility 
post-splenectomy. 22.6: peripheral blood one 
day pre-splenectomy. sp23.6: splenic pulp. 
2.6: peripheral blood six days post-splenectomy. 
27.7: peripheral blood one month post- 
• • 	 splenectomy. The normal range (Dacie and 
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FIGURE 3.4 	The correlation of HS erythrocyte density and 
osmotic fragility. Osmotic fragility curves 
of the total erythrocyte population (A), a 
fraction comprising the top 15% of cells on a 
Percoll density gradient (a), and the bottom 
15% of the gradient (.) are shown. A similar 
but less marked effect was seen post-splenectomy.. 
The fragility test is not sensitive enough to 
detect any such change in normal blood (Cohen 
et al 1976). The normal range (Dacie and Lewis 
1975, p206) is indicated by the dotted lines. 
80. 
FIGURE 3.5 : The appearance of HSerythrocytes pre-splenectomy. 
Total erythrocyte population. Normarski 
optics, xl000 approx. Note the 
spherostomatocytes (arrow) 
Total erythrocyte population stained for 
reticulocytes (arrow). x700 approx. 
C: Top 5% of cells from a Percoll density 
gradient. Normarski optics, xl000 
approx. 
Bottom 5% of cells froma Percoll density 
gradient. Normarski optics, xl000 approx. 
Top 5% of cells stained for 
reticulocytes. x700 approx. 
Bottom 5% of cells stained for 
reticulocytes. x700 approx. Compare 
the size of the stained cells (arrow) 
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Position in gradient (S. D.) 
FIGURE 3.6 : The distribution of reticulocytes in HS erythrocyte 
populations after fractionation on Percoll density 
gradients. The dotted line indicates the 
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FIGURE 3.7 : The decline in mean cell volume (a) and mean cell 
haemoglobin concentration (b) with.position in 
the gradient. Open symbols, HS individuals pre- 
splenectomy. Closed symbols, HS individuals post-
splenectomy. T, total erythrocyte population. 
3.5 	DISCUSSION 	 86. 
The buoyant density of erythrocytes must be determined by 
the composition and arrangement of the cell's component 
molecules but the precise nature and balance of the factors 
affecting erythrocyte density are not fully understood 
(Leif 1970). As the constituents of the red cell e.g. 
haemoglobin, protein, electrolytes, water, lipids etc., 
are often altered in disease it has been suggested 
(Nakashima et al 1973) that measurement of erythrocyte 
density may be of clinical importance. In the absence of 
a quick and easy method of obtaining density distributions 
little progress has been made in evaluating the idea, 
though a later report from Nakashima's group (Oda et al 
1978) showed that useful information was gained from 
three 5ction density distributions obtained by a two 
stage centrifugation through phthalate esters. Percoll 
density gradients allow detailed densiti distributions to 
be obtained, quickly and easily often as part of another 
experiment. Though the data shown in Figure 3.2 is too 
limited to allow generalisation about the clinical 
usefulness of density distributions certain points can 
be made. 
The response to treatment (in this case splenectomy) 
is reflected in the reversion towards the normal 
density pattern. 
The density distributions of the HS erythrocytes both 
pre and post-splenectomy appeared Gaussian. (Only in 
one pre-splenectomy case with a reticulocyte count of 
25% was a band of reticulocytes seen at the top of the 
gradient). This suggests that as in normal (Leif 1970) 
the HS erythrocytes undergo a rapid increase in 
density at the beginning and end of their life span 
but increase their density slowly, in the middle 
87. 
resulting in the "piling up" of erythrocytes at the 
centre of the density distribution. 
3. The observation that a clinically unaffected HS 
individual, J.K., had abnormally dense erythrocytes 
suggests that density measurements could be used to 
detect "carriers" of HS. 
It seems likely from the above that the detailed 
density distributions obtained from Percoll density 
gradients would be of interest in the study of 
erythrocyte abnormalities. The development of a 
method of automatically scanning erythrocytes 
distributed on a broad range density gradient would be 
a useful preliminary to any larger scale study. 
Finally the data described in Section 3.4 shows that 
Percoll density gradients effectively age fractionate HS 
erythrocytes, though the pattern of fractionation of 
pre-splenectomy samples may differ from normal. This must 
be borne in mind when examining the ageing process in US 
pre-splenectomy erythrocytes. 
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4.1 INTRODUCTION 	 89. 
Much work has been aimed at defining the molecular lesion 
underlying hereditary spherocytosis (Section 1.7) but 
little has been done to describe the biochemical changes 
which occur during the lifespan of these abnormal cells. 
It is well established that erythrocyte lifespan is 
shortened in US (Eernisse 1961; Wiley 1970; Garby 1971) 
and the decreased deformability.of the cells is thought to 
play a major part in this (Young 1971), but it is not 
known whether the decreased, lifespan is accompanied by 
an acceleration of the changes seen in normal erythrocyte 
ageing, whether the US cells. are destroyed in their 
metabolic.youth or whether the pattern of events in US 
erythrocyte senescence is abnormal. 
As an initial examination of erythrocyte ageing in US 
three indicators were chosen to reflect quite different 
aspects of the cell's metabolism: the glycolytic enzyme 
pyruvate kinase as an example of an intracellular enzyme, 
acetyicholinesterase as an externally orientated membrane 
enzyme and cell monovalent cation.content which reflects 
membrane permeability and transport functions. 
4.2 METHODS 	 90. 
Pyruvate kinase and acetyicholinesterase assays were 
performed as described in Section 2.2g. Hexokinase 
assays were performed as descrthedby Beutler (1976). 
As activity is lost on freezing, the assays were 
performed on freshly prepared haemolysate or 
haemolysate stored at 4 0C for 16 hours. 
Erythrocyte potassium contentwas measured as 
described in Section 2.2h. Sodium content was 
determined likewise except that the lysates were 
diluted to approximately 3 mg/dl haemoglobin prior 
to flame photometry. 
The pyruvate kinase data displayed in Figure 4.1 was 
pooled in the following manner. It has been reported 
(Piomelli et al 1968) that pyruvate kinase activity 
declines exponentially with position in the gradient 
in. terms of standard deviation from the mean density. 
(In. view, of the many factors affecting pyruvate kinase 
activity (Section 4.3) this relationship may simply 
be fortuitous). Thus when the data is expressed as 
natural log pyruvate kinase activity against standard 
deviations from the mean density, regression lines 
can be calculated by the method of least squares. The 
regression lines, calculated from Figure 4.1 had 
correlation coefficients of -0.72 for normals, -0.84 
for the ES post-splenectomy group and -0.95 for the 
ES pre-splenectomy group. When correlation 
coefficients were calculated for each individual's 
set of data they weze generally<-0.9 i.e. the 
individual sets of data approximated better to a 
straight line than the pooled, data, as might be 
expected. Poorer correlations were obtained when the 
data was expressed in'haemoglobin percentiles or with 
91. 
the pyruvate kinase activity as international units. 
Figure .4.2. was. constructed by reading off points 
from the regression lines from -2,5 to +2.5 standard 
deviations from..the mean density (the range covered 
by the experimental data) and converting the 
co-ordinate from standard deviations back to 
haemoglobin percentiles. These were then converted 
into estimated erythrocyte age in days using the 
linear relationship between age and haemoglobin 
percentile (Section 2.4a) and published figures for 
the lifespans of the. three groups (Section 4.3). 
Pyruvate kinase activity was also converted back to 
the original international units. 
92. 
4.3 PYRUVATE.KINASE ACTIVITY 
The decline in pyruvate kinase activity with position in 
the gradient in terms of haemoglobin percentile (this 
plot giving a linear time scale as discussed in 
Section 2.4a) is shown in Figure 4.1 for 8 normals, 5 HS 
patients post-splenectomy and 3 HS patients pre-splenectomy. 
In all 3 groups there appears to be a rapid initial fall 
followed by a slower decline though the distinction 
between the two phases is less marked in the HS groups. 
A clearer comparison of pyruvate kinase decline can be 
made when anaverage slope is calculated for each set of 
data (see Section 4.3c for. the method of calculation), and 
the.haemoglobin percentile converted to erythrocyte age in 
days using a figure of 120 days for the lifespan of 
normal-erythrocytes (Wintrobe 1974, p195), 96 days for HS 
erythrocytes post-splenectomy (Chapman 1968) and 20 days 
for HS erythrocytes pre-splenectomy. (Eernisse 1961; 
Wiley 1970; Garby and Mollison 1971; Dacie and Lewis 
1975, p461). It is apparent from this type of plot 
(Figure 4.2) that the rate of decline of pyruvate kinase 
activity in the US pre-splenectomy group is rapid whilst 
that of US post-splenectomy individuals is only slightly 
greater than normal. The significance of these 
differences is obscured however by the different levels 
of pyruvate kinase activity in. each group. Pre-
splenectomy the youngest. red.cells have abnormally high 
levels of. pyruvate kinase activity. Premature release of 
reticulocytes into the circulation (stress reticulocytes, 
Section 1.8) may well account for this as may some of 
the factors discussed below. The level of activity then 
rapidly falls to around the normal. level of pyruvate 
kinase activity at 20 days (Figure 4.2). Post-
splenectomy the observed increase in pyruvate kinase 
activity is harder to explain. It is unlikely that the 
increase is due to splenectomy per se as Hanel and 
93. 
Cohn (1975) have reported that pyruvate kinase activity 
decreases post-splenectomy and the one normal 
splenectomised individual available for this study had an 
activity within the normal range (Figure 4.1). Some 
possible explanations are as follows: 
The haemoglobin content of the HS erythrocytes used 
in these experiments ranged from 28.6 - 32 pg i.e. 
within the normal range 29.5 + 2.5 pg (Dacie and 
Lewis 1975, p13). Therefore the increased activity 
cannot simply be explained by lower mean cell 
haemoglobin levels. However the assay employed 
(Beutler 1971) uses total .haemolysate as a source of 
pyruvate kinase. As pyruvate kinase exhibits many 
regulatory properties (Badwey and Westhead 1976) any 
alteration in erythrocyte composition brought about 
by the HS mutation could have a marked effect on the 
measured activity. For example Schafer (1964) showed 
the level of fructose. 1,6-diphosphate (a positive 
allosteric effector of pyruvate kinase) to be increased 
in HS. Thus purification of the pyruvate kinase and 
analysis of haemolysate composition for fructose 
1,6-diphosphate levels may explain the observed 
increase in activity. 
Schroter et al (1978) have reported that a fraction 
(about 10% of the activity in membrane free 
haemolysate) of erythrocyte pyruvate kinase is deeply 
hidden in the lipid layers of the cell membrane. As 
there are many reports of membrane abnormalities 
in. HS (Section 1.7) it is possible that the ES 
membrane composition and arrangement is such that this 
fraction of the pyruvate kinase exhibits increased 
activity. Assay of the pyruvate kinase activity of 
ES membranes may provide evidence for or against 
this hypothesis. 
94. 
Nakashima (1974) reports that there are two 
electrophoretic forms of pyruvate kinase, PKR1  and 
PK2. PKR1  is the predominant form in young 
erythrocytes and is more functional though more 
labile than PKR2.  It is thought that PKR1  converts 
PKR2 during erythrocyte senescence. An alteration 
in the composition of the HS erythrocyte could affect 
the ratio of PKR1  to PK 2 and thus the total pyruvate 
kinase activity. Nakashima (1974) has already reported 
that.in a case of HS with 11% reticulocytes (likely to 
be pre-splenectomy) PKR1  was increased. 
Electrophoretic analysis of the pyruvate kinase of 
the HS post-splenectomy age fractions would be of 
interest. 
There may be more pyruvate kinase molecules in HS 
erythrocytes due to compensatory synthesis during 
erythropoiesis (see Section 1.8) in response to the 
greater energy demand of the leaky ES cell. 
Quantification of the amount of pyruvate kinase 
protein in ES for example by quantitative 
ixnmunoelectrophoresis could resolve this.possibility. 
FIGURE 4.1 	Pyruvate kinase activity decline in normal and HS erythrocytes in terms of 
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FIGURE 4.2. 	The decline in pyruvate kinase activity in normal 
and HS erythrocytes in terms of estimated 
erythrocyte age. 000 ,normals. .. , HS pre-
splenectomy. *- , HS post-splenectomy. 
4.4 ACETYLCHOLINESTERASE ACTIVITY 	 97,, 
Acetyicholinesterase is present in erythrocytes as an 
externally orientated membrane enzyme (Steck 1974). Its 
function in the erythrocyte is not understood and it does 
not appear to be necessary to the cell's survival (Metz 
et. al. 1961). Acetyicholinesterase is sensitive to its 
membrane environment (for example see Aloni and Livne 
1974; Siriwittayakorn and Yuthavong 1979) and its activity 
is altered in a number of pathological states where the 
membrane is clearly affected, for.example in some types of 
autoimmune haemolytic anaemia, ABO incompatibility of the 
newborn (Sirchia et al 1970) and paroxysmal nocturnal 
haemoglobinuria (Siriwittayakorn and Yuthavong 1979). 
Various authors have found that acetylcholinesterase 
activity decreases in the older cells (Cohen et al 1976; 
Kadlubowski and Agutter 1977;.Galbraith and Watts 1981). 
It seems probable that at. least.some of the decrease is 
due to.the 10-15% membrane loss occuring during the 
erythrocyte lifespan (see Section 5.1) as 
acetyicholinesterase is present in vesicles released 
during in vitro erythrocyte ageing (Lutz et al 1977; 
Synder et al 1978) and Galbraith and Watts (1981) using 
quantitative crossed immunoelectrophoresis find decreased 
amounts .of acetyicholinesterase protein in old 
erythrocytes. The discrepancy between the membrane loss 
of 10-15% and the generally reported decrease of 
acetylcholinesterase activity of around 30% may be 
accounted for by Lutz et al's (1977) finding of an 
approximately twofold. increase in acetyicholinesterase 
activity with respect to surface area in the vesicles 
released from erythrocytes during in vitro ageing. 
The age related decreases in acetylcholinesterase activity 
in terms of haemoglobin percentile are shown in Figure 4.3 
98. 
for normal and-HS individuals pre and post-splenectomy. 
A continuous decrease with.. age is observed in contrast to 
the finding of Galbraith. and Watts (1981.) that activity 
increases till around. the middle of the erythrocyte 
lifespan after which it decreases, but in agreement with 
- Cohen et al (1976) and Kadlubowski and Agutter (1977). 
The HS groups.exhibit a wider than normal range in the 
level of activity. It is possible that this is related 
to the membrane abnormalities and heterogeneity of the 
disease. 
Once again the data are better compared when plotted in 
terms of erythrocyte age (Figure 4.4). (For clarity just 
one. example from each group is shown in Figure 4.4 as 
this data cannot readily be pooled). Pre-splenectomy the 
loss of activity is extremely rapid whilst the rate of 
decline.post-splenectomy is similar to normal. The rapid 
decline seen in the pre-splenectomy group could not be an 
artefact of possible poor age fractionation (Section 3.4) 
as this. would. have the opposite effect. The rapid loss 
of activity when the erythrocytes are metabolically 
stressed in the spleen is consistent with the reported 
rapid loss of membrane seen when US erythrocytes are 























FIGURE 4.3 : Acetylcholinesterase activity decline in normal and HS erythrocytes in 
terms of haemoglobin percentile. T, total erythrocyte population. 
>. 
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FIGURE 4.4 : Acetyicholinesterase activity decline in normal 
and HS individuals in terms of estimated 
erythrocyte age.. A , normal. M , US pre-
splenectomy. • , HS post-splenectomy. For clarity 
one example of each group is shown. 
4.5 ERYTHROCYTE SODIUM AND POTASSIUM CONTENT 	101. 
The decline in erythrocyte potassium content with 
haemoglobin percentile is shown in Figures 4.5 and 4.6 
for 7 normal, 5 ES pre and 6 ES post-splenectomy 
individuals. As with the other parameters examined, the 
decline in ES pre-splenectomy potassium levels is rapid 
whilst the decline in the post-splenectomy group is only 
slightly more rapid than normal.. Again the difference 
pre-splenectomy could not be attributed to the 
possibility of poor age fractionation (Section 3.4). It 
is also clear in this case that the potassium content of 
ES pre-splenectomy erythrocytes is diminished. Post-
splenectomy the data suggests that the potassium level is 
increased in the young erythrocytes but decreased in the 
older cells though more data is required to verify this. 
The above findings are in. accordance with the general view 
(see Wiley 1977) that the potassium content of ES 
erythrocytes is diminished. 
The nature of sodium. levels during erythrocyte senescence 
is less clear (Figure 4.7). In normals the levels appear 
to be slightly raised in both the young and old 
erythrocytes. The data of Cohen et al (1976) also 
indicate this. A similar situation is seen in the ES post- 
splenectomy group. Pre-splenectomy the sodium content 
does not appear to be raised in the young red cells though 
more data is required to substantiate this. The sodium 
levels are similar to the 3 groups in agreement with the 
general view (see Wiley 1977) that the sodium content of 
ES erythrocytes is normal. 
As cell potassium content is lowered in ES whilst the 
sodium; content is normal, the cells have an overall 
- 
	
	deficit of monovalent cation. Also as cell volume is not 
significantly altered in ES the monovalent cation 
1 
102. 
concentration wilL be decreased leading to cellular 
dehydration. (See Glader and Sullivan 1979 for discussion 
of the regulation of erythrocyte cation transport and 
cellular hydration). This is presumably one of the major 
causes of the increased density of-HS erythrocytes. 
It-can be seen from Table 4.1 that when the group means 
are considered a high sodium plus potassium content is 
correlated with low density but the association is less 
clear for individuals. This lack of correlation may be 
accounted for by the many determinants of erythrocyte 






















tJ FIGURE 4.5 	The decline in erythrocyte potassium content of normal and HS individuals 













0 	20 	40 	60 	80 	100 	120 
Estimated age (days) 
FIGURE 4.6 	Erythrocyte potassium content decline in normal 
and HS individuals. The regression lines.from 
Figure 4.5 are shown in terms of estimated 
erythrocyte age. 
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FIGURE 4.7 	Alterations in erythrocyte sodium content with 
position in the gradient in terms of haemoglobin 








U moi/g MEAN DENSITY 
SAMPLE ( HAEMOGLOBIN (g/ml, 200C) 
NORMALS 	 1 354 1.0985 
(MALE) 2 325 1.1015 
3 301 1.1011 
4 291 1.1014 
NORMAL MEAN 317.8 1.1006 
US. POST-SPLENECTOMY 
FC 311 1.1050 
(MALE) 
MG 305 1.1071 
AC 298 1.1048 
(FEMALE) 
MF 269 1.1053 
US POST-SPLENECTOMY MEAN 295.8 1.1056 
HS PRE-SPLENECTOMY 
(MALE) 	 DR 226 1.1095 
(FEMALE) 	 EK 280 1.1120 
US PRE-SPLENECTOMY MEAN 253 1.1108 
+ 	+ 
TABLE 4.1 	The correlation of erythrocyte Na + K content 
with cell density. 
4.6 DISCUSSION 	 107. 
The examination of age fractions of ES erythrocytes 
described in this chapter has directly demonstrated for 
the first time some of the molecular changes occurring 
during the shortened lifespan of these abnormal cells. 
(1 	
In the presence of normal circulatory stress, i.e. pre- 
splenectomy, the activity of pyruvate kinase in ES falls 
rapidly from an abnormally high level, presumably due to 
stress reticulocytes (Section 1.8), till at around the end 
of the ES cells' lifespan (about 20 days) the level is 
approximately that of a normal-20 day old erythrocyte 
(Figure 4.2). Thus it appears that in terms of the 
activity, of the intracellular enzyme pyruvate kinase the 
HS erythrocyte is not metabolically old near the end of 
its life. (This does not exclude the possibility that 
due to the supranormal rates of glycolysis needed to 
maintain the cell sodium-potassium balance the level of 
pyruvate kinase is inadequate, though the absence of an 
increased sodium level in any of the age fractions of ES 
erythrocytes pre and post-splenectomy (Figure 4.7) implies 
that the cell's carbohydrate metabolism is adequate to 
maintain sodium pump activity throughout its life in 
spite of the increased influx in ES). However this 
conclusion should be regarded with caution until a 
measurement of the efficiency of age fractionation on ES 
pre-splenectomy erythrocytes is available (see Section 3.4) 
as an increased contamination of the oldest erythrocytes 
with young would increase the activity measured in the age 
fraction. Also if fructose, 1,6-diphosphate levels are 
raised in HS pre-splenectomy erythrocytes (Section 4.3) 
the comparison with normal may be false. The raised 
pyruvate kinase.activity of ES erythrocytes clearly seen 
post-splenectomy merits, further investigation as 
carbohydrate metabolism in ES has not been exhaustively 
108. 
studied and there are no reports of age fractionated 
material being examined. Various lines of enquiry are 
discussed in Section 4.3 
As a preliminary to extending this study of intracellular 
enzyme activity hexokinase activity was examined in the 
age fractions of one ES pre-splenectomy and one normal 
individual. Once again the oldest US erythrocytes did 
not appear to be metabolically old by comparison with the 
normal blood (Figure 4.8). 
In contrast the parameters :reflecting membrane functions, 
acetyicholinesterase activity and cell monovalent cation 
content, indicate that at least in the case of pre-
splenectomy individuals the US erythrocyte ages 
prematurely. 
It has been reported that acetylcholinesterase activity 
can be used as a measure of cell surface area in in 
vitro experiments (Jarrett and Penniston 1976). If this 
is the case in vivo then the data presented in 
Section 4.4 suggests that in. the presence of the spleen 
ES erythrocytes lose as much membrane in their 20 day 
lifespan as normal erythrocytes lose in 120 days. Post-
splenectorny the rate of loss is similar to normal. This 
rapid loss pre-splenectomy would fit with the pathology 
of US deduced from the in vitro behaviour of the cells 
and the histology of the ES spleen (Section 1.7). 
Examination of the potassium of US age fractions reveals 
that pre-splenectomy the cells start with a low potassium 
content which declines drastically during the 20 day 
ilfespan to approximately half that of normal erythrocytes 
at the end of their lifespan (Section 4.5). Post-
splenectomy the erythrocytes appear to start with slightly 
raised. potassium levels but these decrease to subnormal 
109. 
values by the end of their lifespan. It appears then that 
the HS erythrocyte is unable to maintain normal levels of 
potassium even in the absence of splenic stress. 
It is possible that this loss of potassium is caused by 
increased intracellular calcium levels activating the 
erythrocyte Ca ++ sensitive K channel (Lew and Ferreira 
1978). There is good circumstantial evidence for an 
evaluation of calcium in HS. The increase in minor 
components seen in Comassie blue stained acrylamide gels 
of HS erythrocyte membranes can be mimicked in normal cells 
by. the addition of calcium. (Allen et al 1977; Allen and 
Cadman. 1979) and Thompson and. Maddy (1981b) find that the 
depressed phosphorylation at band 2 in HS erythrocytes can 
be mimicked.in normal erythrocytes by introduction of 
calcium into the erythrocyte. In. addition Feig and 
Bassilian (1975) have reported an. elevation of calcium 
in HS erythrocytes particularly prior to splenectomy. 
However Zail and van den Hoek (1976) have challenged 
this though it is not clear if.pre-splenectomy individuals 
were examined by these authors. Attempts were made to 
measure erythrocyte calcium. levels in age fractions of 
both. normal. and US erythrocytes by atomic absorbtion 
spectroscopy. Unfortunately quantitative . readings proved 
impossible with the relatively small amount of material 
available from age fractionation experiments. 
It will be of interest to extend the work presented in 
this.chapter to include, for example, a wider variety of 
enzymes, more detailed enzyme assays, measurement of cell 
membrane components, calcium-determinations and to use 
radioactive cohort labelling to allow actual measurement 
of the age of a given fraction and separation efficiency. 
110. 
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FIGURE 4.8 : The decline in hexokinase activity with 
estimated erythrocyte age for one normal (•) 
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5.1 INTRODUCTION 	 112. 
The results of the previous chapter indicated that in pre- 
splenectomy individuals the HS erythrocyte ages more 
rapidly than normal in terms of the plasma membrane 
functions, acetyicholinesterase activity and potassium 
permeability. In view of this, the implication of plasma 
membrane alterations in various models of erythrocyte 
ageing (Section 1.5), and the observation that plasma 
membrane dysfunction appears to be a common denominator 
in the premature demise of abnormal erythrocytes (Glader 
and Sullivan 1979), plasma membranes isolated from 
erythrocyte age fractions of both normal and ES 
individuals were examined for age related changes. As 
time and sample size did not permit an exhaustive membrane 
analysis two important aspects of the membrane which have 
previously been little studied in age fractionated 
erythrocytes were examined: membrane polypeptide 
composition and cell surface labelling by 
lactoperoxidase-catalised iodination. 
Erythrocyte membrane composition during ageing 
There have been various studies of the effect of age 
on membrane composition in normal erythrocytes but not in 
ES erythrocytes as these have not previously been age 
fractionated. It has been established that normal 
erythrocytes lose 10-15% of their surface area during 
ageing (Westerman et al 1963; van Gastel et al 1965; 
Canham 1969; Greenwalt and Lau. 1978), and this loss is 
reflected in a similar decrease in membrane lipid 
(Westerman et al 1963; van Gastel et al 1965; 
Winterbourne and Batt 1970) and carbohydrate, including 
sialic acid (Cohen et al 1976; Seaman et al 1977; 
Baxter and Beeley 1978; Choy. et al 1979). Whether 
membrane protein decreases with age is unclear. 
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Cohen et al (1976) report a decrease such that the lipid 
protein ratio remains constant. Shiga et al (1979) on 
the other hand find no decrease with age and relate the 
resultant increased protein to lipid ratio to an age 
related decrease in membrane fluidity. The situation is 
likely to be complex as Sears (1973) and Sears et al 
(1975) have found that during in vitro ageing loss of 
surface protein occurs whilst cytoplasmic proteins are 
accreted to the membrane. 
There is general agreement thatthe relative amounts of 
the major phospholipids do not change with age 
(Westerman et al 1963; van Gastel et al 1965; 
Winterbou.rne and Batt 1970).. Some authors report a decrease 
in the cholesterol: phospholipid ratio (Westerman et al 
1963; van Gastel et al 1965) whilst others find no change. 
(Cohen. et al 1976; Shiga et al 1979). Van Gastel et al 
(1965) and Shiga et al (1979) find an age related 
decrease in arachidonic acid and increase in linoleic 
acid. 
Little has been done to analyse membrane polypeptide 
composition during ageing. Two groups (Allen et al 1977; 
Kadlubowski. 1978a,b) have, examined the polypeptide 
composition of erythrocyte age fractions obtained by the 
Murphy method (Section .2.1) using polyacrylamide gel 
electrophoresis in.the presence of SDS (SDS-PAGE) and 
found no qualitative differences. However neither group 
used. the gel system recommended for comparison of 
erythrocyte membrane composition, Laemmli slab gel 
electrophoresis (Anselstetter 1978), or erythrocytes 
fractionated by the superior technique of density gradient 
centrifugation. In the first part of this chapter such an 
analysis is described for normal and HS subjects. 
Erythrocyte surface changes with age 	 114. 
Though it has been hypothesised (Section 1.5) that a 
change in the erythrocyte surface must occur to allow 
recognition. of senescent erythrocytes by the 
reticuloendothelial system, the effect of ageing on the 
erythrocyte surface has only been examined by indirect 
techniques such as electron microscopy of cells treated 
with positively charged colloids (Nordt 1980) and lectin 
binding (Marikowski et al 1976; Choy et al 1979). To 
obtain a. more.detailed picture of the cell surface with 
age erythrocytes were surface labelled with 125I using 
the. lactoperoxidase method, age ...fractionated and the 
iodinated polypeptides examined, by a sensitive two 
dimensional SDS-PAGE. system developed in this laboratory 
(Thomson et al 1980). 
In addition the amount of 
125 
 surface label was 
quantified. This was done for two reasons: 
1. As no qualitative difference in the surface 
labelling pattern was observed during ageing 
(Section 5.4) the amount of surface label per cell 
should. correspond to cell surface area, assuming that 
the iodinated proteins are labelled to the same 
extent throughout the erythrocyte lifespan. If the 
amount of label. does.not correspond to the reported 
10-15%.. decline in surface during senescence the 
altered amount of iodination could indicate a change 
in. membrane architecture. It has been hypothesised 
(Mordt. 1980) that age related alterations in membrane 
architecture caused by membrane loss during ageing 
may be responsible for. the observed properties of 
senescent erythrocytes. e.g. increased phagocytosis by 
macrophages (Kay 1978) and altered surface charge 
topography (Nordt 1980). 
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2. If surface label can be used as a measure of cell 
surface area it should be possible to determine 
whether, as suggested by the rapid loss of 
acetylcholinesterase activity and in vitro membrane 
loss (Section 4.4), HS erythrocytes pre-splenectomy 
rapidly lose membrane material as they age. Also by 
relating. the amount of surface label in HS to other 
membrane constituents the possibility that the 
friability and abnormal shape of the US. cell is due 
to an. imbalance of otherwise normal components 




a: Erythrocyte suspensions were prepared as described 
in Section .2.2a and washed three times in Hepes 
buffered isotonic saline (133mM NaCl, 4.5mM KC1, 
10mM Hepes, pH 7.4) (Buffer A) just before use. 
b:. Erythrocyte membranes (ghosts) were prepared at 4 °C 
by lysing approximately 1 x 10  erythrocytes with 
10. ml. of 5mM sodium. phosphate buffer (pH 7.2) and 
centrifuging the resultant suspension at 38,000 x g 
for 25 minutes. The pink ghost pellet was then washed 
with 10 ml of 5mM sodium phosphate buffer (pH 7.5) 
and recentrifuged to yield. an off-white ghost pellet. 
In age fractionation experiments care was taken to 
prepare ghosts from equal cell.numbers. To exclude 
the possibility of significant loss of surface material 
during ghost preparation the ghost supernate was 
centrifuged at 100,000 x g.for 2 hours.. No pellet was 
visible and analysis of the lic$d at the bottom of the 
tube by Laemmli SDS-PAGE failed to show membrane 
components. Also 
125
I labelled whole cells were 
examined.by two-dimensional. SDS-PAGE. An identical 
surface label pattern to. that of the ghosts was seen, 
125 
though due to. the high protein: 	I ratio in the 
whole cell there was.too little radioactivity on the 
gel to enable detection of. minor components. 
C:. Ghosts were prepared for PAGE by the addition of one 
volume of 0.125mM Tris-HC1 containing 10% (w/v) SDS, 
20% (.w/.v) glycerol,. 0.002% bromophenol blue, 1mM EDTA 
and 80mM dithiothreitol, final pH 6.8 (double 
strength sample buffer) .to one volume of ghost 
suspension. This mixture was immediately heated for 
5 minutes at-100 
0 
 C to inactivate proteases and 
maximise protein solubilisation. Whole cells were 
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prepared. for PAGE by the addition of 15 volumes of 
single strength sample buffer to one volume of packed 
cells fcllowed.. by 5 minutes at 100 °C. 
d:. One-dimensional SDS-PAGE 
Samples were analysed either in the discontinuous 
buffer system of Laemmli (1970). or in the continuous 
buffer system described by Fairbanks et al (1971). 
The slab apparatus used was that. first described by 
Reid and Bieski.(1968) and later modified by Studier 
(1973). The. slab gels were 15 cm wide, 14 cm high 
and.l..5 mm thick. A 14 sample comb was used, each 
sample well 7 mm. wide, 15 mm deep and 3 mm apart. 
In. the Laemmli system a stock.solution of 30% 
acrylamide, 0.8% bis-acrylamide was used to make 11.5% 
acrylaxnide separation gels and 5% acrylaxnide stacking 
gels. (All the percentages given in this section are 
w/v unless otherwise stated). The separation gel 
buffer was 0.375M Tris-EC1, 0.1% SDS. Pre-set Tris-
HC1.crystals (pH 8.7 at 25°C, Sigma) were used to make 
this buffer. This was found to be essential for high 
resolution.gels. The gel.was polymerised by the 
addition of 0.01 volumes of 10% ammonium persulphate, 
0.0007 volumes of TEMED and overlaid with separation 
gel buffer.. The gel was left for at least 2 hours 
before the stacking gel was added. The stacking gel 
buffer was 0.125M Tris-HC1, 0.1% SDS, pH 6.8. 
0.01 volumes of 10% .ammonium persulphate and 0.0007 
volumes, of TEMED were mixed with the gel solution to 
achieve polymerisation in approximately 20 minutes. 
The gel was used immediately. Electrophoresis took 
approximately 4 hours at a constant current of 30mA. 
The, electrode buffer was 0.025 M Tris, 0.192M glycerine, 
0.1% SDS, pH 8.3. 
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In the Fairbanks system an acrylamide. stock solution 
of 40%acrylamide, 1.5% bis-acrylamide was used to 
make 4% acrylamide slab gels. The gel buffer was 
0.04M Tris, 0.02M sodium acetate, 2mM EDTA, 0.5% SDS, 
final pH 7.4. Polymerisation.was achieved by the 
addition.of 0.01 volumes of 10% ammoniuzn persuiphate 
and 0.0005 volumes TEMED and the gels left overnight 
before.use. Electrophoresis took approximately 4 hours 
at a constant current of 40mA. The electrode buffer 
was.0.04M Tris, 0.02M sodium acetate, .2mM EDTA, 0.1% 
SDS, final pH 7.4. 
e: Two-dimensional SDS-PAGE 
To produce a two-dimensional pattern the samples were 
first run in a Fairbanks slab gel (1.5 mm thick) with 
an empty well between the samples. After 
electrophoresis strips (7-8 mm wide) containing the 
electrophoresed:sample.. were cut from the slab and 
equlibriated for 30 minutes in Laemmli sample buffer, 
0.0625M Tris HC1, pH 6.8, 5% (w/v). SDS, 10% (w/v) 
glycerol, 0.5mM EDTA and 5% (v/v) inercaptoethanol. 
The strips were then either run in the second dimension 
(a Laemmli slab gel) immediately or stored at -20 °C 
for-up to-3 weeks. (Lonqer periods of storage led to 
dehydration.. and shrinkage). The Laemmli gels used for 
the second dimension were prepared as for the one-
dimensional gels but made 1.75mm thick and the 
stacking.gel was 1.5 cm high with a flat surface 
itself 1 cm below the buffer surface. To run the 
second dimension a strip from the first dimension was 
placed above the stacking gel, fixed into place with 
1% (w/v) agarose in electrode buffer containing 0.001% 
bromophenol blue as a marker dye and subjected to 
electrophoresis for approximately 4h at 30 mA. 
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Protein on the gels was visualised by staining with 
0.025% Comassie Brilliant Blue R250 in acetic acid! 
methanol/water (1 : 1 : 8, v/v/v) for 18 hours and 
destaining with acetic acid/methanol/water (1 1 : 1 
v/v/v) for approximately 48 hours. 
Radioactive material was detected by autoradiography 
of gels dried down on Whatman No. 17 filter paper 
against Kodak X-Omat H film, or if appropriate by 
counting slices of the gel with a Nuclear Enterprises 
automatic gamma spectrophotometer NE 8311 (efficiency 
approximately 40%). 
Surface labelling with 125 
Labelling was achieved by lactoperoxidase catalysed 
iodination using H 2 0 2  generated by the glucose 
oxidase system of Hubbard and Cohn (1972). 1 ml of 
incubation mixture contained 1 x 10 cells in Hepes 
buffered isotonic saline (buffer A, Section 2.2), 
5 mM glucose, 0.1 ug glucose oxidase (Sigma, Type V) 1 
10 ,ug lactoperoxidase (Sigma, powder) and 50 iCi 
125 	 0 
Na 	I. .Incubations were carried out at 37 C for 20 
minutes and then the reaction was terminated by the 
addition of 10 ml of buffer A (4°C), containing 
10 pM Na2S205 . The cells were then washed at 4°C 
three times with further 10 ml aliquots of this buffer 
and twice withthis buffer containing 5 pM KI to remove 
any free Na 125i  Non-specific labelling (control 
without lactoperoxidase) was less than 0.5%. 
TCA. precipitation 
200 )i1 samples of haemolysate were mixed with 2 ml of 
10% (w/v) TCA and left at 4 °C for 18 hours. 
Co-precipitant was not necessary due to the high 
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protein content (mainly haemoglobin) of the samples. 
The precipitate was then collected on Whatman G/LC 
glass fibre filters, washed with 4 x 2.5 ml of 5% TCA 
and radioactively measured. with a Nuclear Enterprises 
automatic gamma spectrophotometer NE 8311 (efficiency 
approximately 40%). 
h:. Rocket Immunoelectrophoresis 
1 mm thick gels (10 x 15 cm) were poured on the 
hydrophilic side of Gel Bond film. The gel solution 
contained 1% (w/v) agarose (Indubiose A37), 1% (w/v) 
deoxycholate, 1% (w/v) Triton X-100, 1% anti-human 
serum. albumin (Behring, Behringwerke AG, Marburg, 
W. Germany) in 0.lNTris, 4mM EDTA, 15mM. boric acid, 
pH 8.9. 3 mm sample wells were cut 2 mm apart and a 
5 il sample added. The electrode buffer was 0.1M 
Tris, 4mM EDTA, 15 mM boric acid pH 8.9 containing 
1% Triton X-lOO and .1% deoxycholate. Treble 
thickness 18 cm paper wicks were used and the gel 
was electrophoresed at 50V/cm.for 2 hours. To 
visualise protein.the gel was dried with a hairdrier 
then stained with 0.25% Comassie Blue R in acetic 
acid/methanol/water (10:45:45, v/v/v) for 10 minutes 
followed by 15 minutes destaining in acetic acid! 
methanol/water (1 : 4 : 5, v/v/v). 
5.3 ERYTHROCYTE MEMBRANE POLYPEPTIDE COMPOSITION 	121. 
DURING AGEING. 
Examination of the membranes of normal erythrocytes age 
fractionated on Percoll density gradients by Laemmli 
SDS-PAGE revealed no qualitative change in polypeptide 
composition except for the appearance of a strong band 
in the oldest fraction with an apparent molecular weight 
of 68,000 (Figure 5.1). The same result was obtained with 
!SCU'\ 	 k0 ra4c 	(ckj,$) 
ES erythrocytes.' 10 normal, 5 ES pre. and 5 ES post-
splenectomy individuals were. examined. Preliminary attempts 
were made. to identify this component. Under non-reducing 
conditions it migrated more rapidly giving an apparent 
molecular; weight of 55,000 (Figure 5.1) a behaviour 
characteristic of serum albumin (Owen et al 1980). It 
could also not be.distinguished from human serum albumin 
in. comigration experiments. However attempts to identify 
the. band as human serum albumin immunologically by 
rocket ixnmunoelectrophoresis were unsuccessful (Figure 5.2). 
The experiment was repeated six times using three 
different blood samples. Correct loading was ensured by 
estimating the amount of 68,000 protein in a sample from 
the intensity of the band in SDS-PAGE.. The possibility 
that the component was BSA from the gradient medium was 
excluded by performing the age fractionation in the 
absence of BSA. 
Conflicting results were also obtained with 
125
I surface 
labelling. In five experiments where age fractionated 
erythrocytes were surface. labelled and the iodinated 
components subsequently analysed by autoradiography of 
Laemmli. gels (labelling and analysis performed by 
Dr. S. Thompson), the band appeared to be labelled. 
However this result was confused by the finding in one 
experiment that all fractions showed a labelled 68,000 
peptide but only the densest showed the 68,000 Comassie 
122. 
stained band. Also, in .a subsequent experiment performed 
by the author where erythrocytes were labelled prior to 
age fractionation no labelling of the 68,000 band was 
apparent. No simple explanation, of these anomalies can 
be suggested. 
123. 
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FIGURE 5.1 : The membrane polypeptide composition of age 
fractionated normal erythrocytes. 1-5 fractions 
of increasing age. (1 and 5 contain 
approximately the top and bottom 5% of the 
erythrocyte population). T, total erythrocyte 
population, 5R, bottom 5% of erythrocytes, 
sample reduced. 5U, bottom 5% of erythrocytes, 
sample unreduced. Note the shift in the 
68,000 canponent (arrow). The polypeptides 
are numbered as in the Fairbanks system. 
The dye front is just below the globin chains. 
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FIGURE 5.2 : Rocket immunoelectrophoresis of solubilised age 
fractionated erythrocytes against anti-human 
serum albumin. 1-5 fractions of increasing age. 
T. total erythrocyte population. W, whole cells 
solubilised in 5mM phosphate buffer pH 7.2 
containing 4% Triton X-lOO, 2% deoxycholate, 
0.5mM EDTA. G, ghosts solubilised in the same. 
The faint rocket produced by the whole cell 
total erythrocyte population (arrow) may be due 
to unbound serum albumin remaining after the 
3 x 10 ml wash of the cells as the technique can 
detect as little as 5 rig of serum albumin. 
5.4 ERYTHROCYTE CELL SURFACE PROTEINS DURING AGEING 	125. 
To examine cell surface proteins during ageing 
erythrocytes were surface labelled with 
125
I using the 
lactoperoxidase method, age fractionated and the iodinated 
polypeptides. analysed by a two-dimensional SDS-PAGE system 
developed in.-this laboratory (Thompson et al 1980) which 
exploits the different mobilities of glycoproteins in the 
Fairbanks and Laemmli PAGE systems. This technique was 
found.to be more informative than two-dimensional systems 
involving isoelectric focussing which have so far been of 
limited use in the analysis of erythrocyte membrane 
proteins (for. example see Rubin and. Milkowski, 1978). 
AComassie blue.stained two-dimensional gel (Figure 5.3) 
does not give much more detail than the one-dimensional 
Laemmli gel though band 3 migrates as a large diffuse area 
away from the main polypeptide arc revealing four or five 
components obscured. in the one-dimensional system and it 
becomes apparent that band .2..l migrates as a band 1 
component. in: Laemmli gels. An autoradiographed gel 
(Figure 5.4) is much more informative-revealing many 
surface labelled components that.. are not apparent in the 
Comassie blue stained gel. (For identification of these 
components see Thompson et al 1980; Thompson and Maddy 
l98]. 
When age fractionated normal. erythrocytes were examined 
identical patterns, to those illustrated in Figures 5.3 
and 5.4 were found in all fractions. The 68,000 
component seen in the oldest erythrocytes in Laemmli gels 
could not be identified in the two-dimensional gel 
possibly due to the poorer resolution of the Fairbanks 
dimension in this molecular weight region. The surface 
labelling pattern of US erythrocytes was found to be normal 
in 10 US individuals, (5 pre, 5 post-splenectomy). In a 
126. 
preliminary study of 2 HS pre-splenectomy individuals 
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FIGURE 5.3 	The two-dimensional Cornassie staining pattern of 
erythrocyte membrane polypeptides. (Photograph 
courtesy of Dr. S. Thompson). Inset 1, 2, and 2.1 






FIGURE 5.4 	An autoradiograph of surface labelled components 
of erythrocyte membranes. (Photograph courtesy 
of Dr. S. Thompson). For identification of 
the components see Thompson et al 1980, Thompson 
and Maddy 1981. An identical pattern was 
observed in all age fractions of normal and HS 
individuals. 
5.5 QUANTIFICATION OF 125  I SURFACE LABEL DURING SENESCENCE 129. 
As any age related differences were expected to be small 
and as preliminary experiments found the labelling level 
to be critically dependent on cell concentration (also 
reported by Howard et al 1980) erythrocytes were labelled 
prior to.age fractionation. The labelling procedure did 
not affect erythrocyte density. 
125 a: 	I Surface. Label per Cell 
To quantify 
125
I surface.label per cell, washed age 
fractionated erythrocytes were lysed with 5 ml of 5mM 
sodium. phosphate buffer (pH 7.2) and samples taken 
for haemoglobin estimation and measurement of radio-
activity: counts in the.lysate (liquid sample) and a 
TCA precipitate of the lysate were obtained and the 
results expressed-as counts per minute per jag 
haemoglobin. The lysate contains both labelled protein 
and residual free I, TCA precipitate contains only 
the former. The identical labelling pattern of the 
age fractions . (Section 5.4) argues against the 
possibility of old erythrocytes being 'leaky' with 
respect to the iodination system and therefore 
internally labelled. 
In. the course of these experiments it was found that 
contaminating cellulose fibres and particles (from 
the.ceIlulose: cx cellulose column used to remove 
white cells and platelets) were causing spurious 
results. These could.mostly be removed by spinning 
the lysates at 100 x g for 3 minutes,. or their presence 
circumvented by removing white cells and platelets as 
buffy coat. The latter procedure however also removes 
the youngest erythrocytes (Beutler et al 1976) so 
experiments were performed with both methods. The 
130. 
results of 4 experiments, 2 with the cellulose removed 
by centrifugation, 2 with buffy coat removed blood, are 
shown.in Figure 5.5. A downward trend is seen in each 
experiment and when the data.from.fractions comprising 
approximately the top and bottom 10% of the erythrocytes 
is considered the percentage decline in label is 
consistent with the. reported percentage loss of surface 
area during in vivo ageing in three of the 4 experiments. 
(Table 5.1). To assess .the statistical significance of 
the data further replicates were taken for TCA 
precipitation with buffy coat removed blood, giving a 
total of .4 in experiment c and 6 in experiment d. The 
mean values ± the standard error of the meanare shown in 
Figure 5.6. By Student's t test the difference between 
the top-and bottom fractions was. significant, p <0.005 
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FIGURE 5.5 	The level of 125i  surface label with erythrocyte 
age. Open symbols, lysate, Closed symbols, 
TCA precipitate. Experiments a and b used 
erythrocytes purified by cellulose filtration. 




% DECREASE _________________  
TOP 10% BOTTOM 10% 
a 4.03 3.88 3.7 
b 3.24 2.5 22.2 
c 6.78 5.52 18.,5 
d 29.7 25.8 14.2 
APPROXIMATE SIZE OF FRACTIONS 
AUTHOR 
(% TOTAL ERYTHROCYTES) 
REPORTED SURFACE AREA DECREASE 
TOP BOTTOM 
Westerman et al 	1963 10 10 9.3 
van Gastel et al 	1965 14 14 10.5 
Canhajn 	 1969 20 10 11 
Greenwalt and Lau 	1978 15 15 11 
TABLE 5.1 	 125 The correlation of decreased 	I surface label 
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FIGURE 5.6 : The level of 125  surface label with 
erythrocyte age. The bars indicate the standard 
error of the mean. 
5.6 DISCUSSION 	 134. 
The constancy of erythrocyte membrane polypeptide 
composition with age described in Section 5.3 is in general 
agreement. with the.findings of others (see Section 5.1) 
though. the appearance of a 68,000.polypeptide in the 
oldest erythrocytes is previously unreported. The 
relationship of this component to serum albumin is 
intriguing, as discussed in Section 5.3, but without further 
work no.conclusions can be drawn. 
Recently Kay (1981) has reported the isolation of an 
antigen from senescent erythrocytes which is recognised and 
bound by an autoantibody in the serum resulting in 
erythrophagocytosis. This antigen was also shown to be 
present on stored lymphocytes and possibly on platelets, 
macrophages, neutrophils and senescent cultured cells and 
had an' apparent molecular weight of 62,000 as determined 
from Fairbanks gradient gels. As many proteins migrate 
differently in the two systems and steep gradient gels 
were used it is possible that the antigen is the 68,000 
component described in Section 5.3 Unfortunately Kay did 
not, directly analyse the membranes of senescent 
erythrocytes and the data presented did not allow 
quantification of the protein. It is tempting however to 
speculate that. near the end of the erythrocyte's life a 
membrane change allows binding of serum albumin which is 
or becomes modified so that it is no longer reactive with 
anti serum albumin but reacts with the autoantibody 
described by. Kay resulting in the phagocytosis of the 
erythrocyte. The identification of Kays antigen as 
modified serum albumin could explain its presence on other 
blood cells. 
The constancy of HS membrane polypeptide composition with 
cell age indicates that the premature demise of the cell 
135. 
is not due to the appearance of a gross membrane protein 
defect. However the presence of the 68,000 component in 
the oldest HS erythrocytes both pre and post-splenectomy 
suggests, as.did the acetyicholinesterase and potassium 
data. in the last chapter, that the membrane of these 
erythrocytes has prematurely aged. 
Preliminary results were obtained from.the cell surface 
labelling experiments (Sections 5.4 and 5.5). The surface 
of the HS.erythrocyte appeared normal and no age related 
surface change .was detected in either normal or US by the 
_—two--dimensional. SDS-PAGE. analysis of iodinated surface 
polypeptides. Quantification of the label in. normal subjects 
revealed a decrease with age consistent with the reported 
loss of surface area during erythrocyte ageing (Table 5.1) 
i.e. 1251  surface label appears to be quantitatively as 
well, as qualitatively constant per unit membrane area. 
Thus any putative age related alteration in membrane 
architecture-(Section 5.1) has. not been detected by 
quantification .of 
125
I surface label. It will be of 
interest, to extend this work to US erythrocytes for the 
reasons. given in Section 5.1. 
There have - been many studies . in recent. years of the loss 
of membrane material, from erythrocytes incubated in vitro 
("in vitro ageing") under various conditions (e.g. Lutz 
et al. 1977; Lutz 1978; Allen. and Michell 1979; Bocci et 
al 1979). Although the precise composition of the material 
released varies with experimental conditions, a common 
feature is the release of vesicles similar in composition 
to the plasma membrane but. depleted in spectrin. If 
membrane loss occurs in vivo in a similar manner then the 
membrane of senescent erythrocytes should be slightly 
enriched in spectrin. As surface label appears 
quantitatively constant per unit membrane area (see above) 
it should .be possible to detect spectrin enrichment by 
measuring the ratio of surface label to spectrin in the 
136. 
age fractions. This was attempted. as follows: 
Iodinated age fractionated erythrocytes were lysed with ice 
cold 5mM sodium phosphate buffer (pH 7.2) and diluted with 
the same to give samples of equal haemoglobin concentration. 
10 ml aliquots were then used to prepare ghosts 
(Section 5.2b) which were subsequently electrophoresed on 
4% Fairbanks gels. These gels give good separation of 
bands 1 and 2. (spectrin) from each other and from lower 
molecular weight components.. After electrophoresis the 
gels were stained (Section 5.2e), scanned with a Joyce-
Loebl recording microdensitometer and the amount of 
protein in bands 1 and 2 estimated from the area under the 
peaks. Finally the gel was sliced into strips, the 
radioactivity in the strips measured and the results, 
surface label: spectrin ratio, expressed as counts per 
minute per unit area. Samples to be compared were run on 
the same slab gel. It was checked that there was no age 
related change in either the recovery or distribution of 
radioactivity on the gel and there was no evidence of age 
related retention of. material, at the top of the gel either 
in. these experiments or in experiments involving 
32 
 P 
labelled'. spectrin. performed by Dr. A.H. Maddy and 
Dr. S. Thompson. To control for the possibility of age 
related loss of spectrin this experiment was also 
performed.using whole cells for electrophoresis. A clear 
separation. of bands 1 and 2 was obtained with these 
preparations and any residual free iodine in the cells was 
run of f.the bottom of the gel. 
The results of three experiments,, one using ghosts, two 
using whole cells, are shown in Tables 5.2 and 5.3. 
The higher counts in the whole cell experiments were 
thought to reflect the use of a fresh batch of isotope 
rather. than the technique. It is obvious, from the 
variability of the results that many replicates should be 
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run to establish whether the technique is accurate enough 
to allow detection of the expected small difference. 
The.most likely source of.error is the estimation of the 
amount of spectrin from gel scans. The problems of 
quantification of erythrocyte membrane proteins by gel 
scanning are discussed fully by Kadlubowski (1978a). 
Quantification of spectrin by other methods e.g. 
immunoelectrophoresis may prove to be a more successful 
approach. In view of. the importance of establishing the 
relevance of in vitro ageing to. the. situation in vivo it 




(BANDS 1 	8) 
AREA UNDER 
BANDS 
1 AND 2 
(ARBITARY 	UNITS) 
CPM / UNIT 
AREA 
TOP 4002 .128.5 31.1 
MIDDLE 	. . 3547 	 . 117 30.3 
BOTTOM 	 . . 4179 121 . 	34.5 
TOTAL 	 . 3190 117.7 27.1 
I-. 
TABLE 5.2 : 	The surface label spectrin ratio of age 	 co 
fractionated, normal erythrocytes. 
CPM AREA UNDER 
IN GEL BANDS LAND 2 CPM / UNIT 
FRACTION (BANDS 1 - 8) (ARBITORy UNITS) AREA 
NORMAL 
TOP 17600 75.5 233.1 
MIDDLE 19570 86.5 226.2 
BOTTOM 17478 70 249.7 
TOTAL 15700 67.5 232.6 
HS PRE-SPLENECTOMy 
13958 101.5 137.5 TOP 
MIDDLE 12287 113 108.7 
BOTTOM 10143 79 128.4 
TOTAL 15209 109 139.6 
TABLE 5.3 : The surface label : spectrin ratio of age 
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6.1 NORMAL. .ERYTHROCYTE AGEING 	 141. 
In the search for a molecular explanation of erythrocyte 
ageing and destruction there have been many but often 
contradictory reports of age related changes (Sections 1.5 
and. 5.1) and as yet there is no clear evidence to support 
any - of the five major.hypotheses of senescence outlined 
in Section 1.5. Progress has been limited by (1) the 
technical . difficulties of .age fractionation and of 
accurately determining the apparently small changes 
involved, in erythrocyte senescence and (2) a lack of 
appreciation.. of the circulatory microenvironment on 
erythrocyte metabolism. 
(1) The inadequacies of existing erythrocyte age 
fractionation.methods. have .already been discussed 
(Chapter 2). Though the rapid. and gentle Percoll 
density gradient method described in this thesis 
clearly has advantages, further development of age 
fractionation methods is likely to be required for 
the. following reasons. It is possible that the most 
senescent.erythrocytes become damaged and swell 
Just before removal from the circulation (Kirkpatrick 
et.al .1979) in which case the.densest cells, though 
they are among the oldest erythrocytes, will not 
contain the most senescent erythrocytes. Perhaps 
more importantly, the most. likely sites of 
erythrocyte ageing in vivo are where the red cells 
become transitorily trapped and concentrated e.g. the 
splenic pulp (Bocci 1981) and therefore, if effete 
cells are efficiently removed from the circulation, 
the most senescent cells will not be present in 
peripheral blood, the normal. starting material for age 
fractionation studies. The. above considerations 
suggest.. that examination of erythrocytes trapped in 
the spleen may be necessary to unravel the terminal 
142.. 
events in senescence. As the spleen sequesters cells 
of all ages and especially reticulocytes (Crosby 1977) 
purification of the most senescent erythrocytes will 
still be necessary, preferably by a technique that does 
not. involve cell density. If the 68,000 polypeptide 
found in the densest. peripheral erythrocytes is an 
ageing signal (Section 5.4) techniquexploiting 
antibody raised to this component e.g. affinity 
chromatography or fluorescence.activated cell sorting 
could be developed. . Such techniques applied to 
peripheral blood. may also enable. the large quantities 
of senescent .erythrocytes required todetect minor 
differences to be more readily obtained. 
(2) It has been appreciated for some years that the 
conditions of high haematocrit, low pH and low p0 2 
in the splenic pulp (Levesque and Groom 1976 a, b) 
favour metabolic depletion of erythrocytes and release 
of.microvesicles in vitro. (For review see Bocci 1981). 
However the effect of circulatory shear stress on 
erythrocyte metabolism has only just been examined. 
Larsen. et al (1981) have made the pertinent discovery 
that physiological levels, of shear stress increase the 
passive Ca permeability of erythrocytes by up to an 
order of magnitude and.strongly enhance Ca stimulated 
ATPase activity. This suggests that the many 
biochemical events which are.sensitive to intracellular 
Ca ++ may be in a more dynamic state than had previously 
been thought. An example ofthis which is of 
particular. relevance to the description of erythrocyte 
ageing is that. microvesiculation (discussed in 
Section 1.5). may' occur.in vivo as a result of increased 
intracellular Ca levels caused by shear stress rather 
than following AT? depletion during splenic trapping. 
6.2 HEREDITARY SPHEROCYTOSIS 	 143. 
The use. of Percoll density gradients to age fractionate ES 
red-cells has yielded interesting information about the 
mechanism. of premature erythrocyte senescence in ES 
(Chapters.3 and 4). The possibility that a defect may 
have been obscured by examination of total erythrocyte 
population has also been ruled out. 
In view of the various membrane abnormalities in ES it is 
currently expected that the underlying lesion will be a 
defective membrane. component(s). However, as yet there is 
no clear evidence for this and it is quite possible that 
the membrane abnormalities observed are secondary to a 
mutation in a cytoplasmic component, as occurs in sickle 
cell.anaemia and pyruvate kinase deficiency. It will be 
of interest therefore to screen ES erythrocyte lysate 
proteins for-abnormalities, for example using the two-
dimensional mapping technique described by Edwards et al 
(1979) . 
It.. is also possible. that there is no abnormal component in 
the mature ES .erythrocyte. As it has-been shown that ES 
red cells .are defective by the reticulocyte stage of 
maturation (Sections. 1.7 and 3.3) it may be that an 
abnormality early in erythropoiesis results in the 
production of an abnormal. erythrocyte built of normal 
components i.e. the stochiometry and/or arrangement of the 
cell may be altered. Indeed following from the bilayer 
couple hypothesis of Sheetz.and.Singer (1974), the 
spherostomatocytic shape of ES erythrocytes suggests that 
the kaAer. membrane leaflet is expanded with respect to the 
ber leaflet.. Clearly examination of the early stages of 
erythropoiesis is.an important-next step in unravelling 
"the continuing enigma" of hereditary spherocytosis. 
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APPENDIX I 	ABBREVIATIONS 
Widely accepted abbreviations, e.g.-ATP, have been used 
without definition as described in the Biochemical Journal 
"Policy of the Journal.and Instructions to Authors Biochem. J. 
(1981) 193, 1-27. 
Other abbreviations used in the text are as.follows: 
BSA.. Bovine serum albumin 
1,2-DG 1, 2-diacyiglycerol 
2,3-DPG .2,3-diphosphoglycerate 
ES Hereditary. spherocytosis 
Hepes N-2-hydroxyethylpiperazine-N1-ethanesulphonic acid 
Ig Ixnmunoglobulin 
MCV Mean cell volume 
MCHC Mean cell haemoglobin concentration 
PAGE Polyacrylamide gel electrophoresis 
PEP Phosphoenolpyruvate 
SDS Sodium dodecyl sulphate 
SDS-PAGE Polyacrylamide gel electrophoresis in the 
presence of SDS 
TCA Trichloracetic acid 
TEMED N,N,N,N' - tetramethylethylene diamine 
Journal, titles are abbreviated as described in Serial 
Sources for the Biosis Data Base, Volume 1981. 
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Summary 
A new rapid method for the age fractionation of human erythrocytes by cen-
trifugation through a "Percoll" density gradient is described. The fractionation 
is demonstrated by density-related changes in the volume, haemoglobin concen-
tration, pyruvate kinase and acetylcholine esterase activities and potassium con-
tents of the erythrocytes, and the distribution of reticulocytes on the gradients. 
Introduction 
The fractionation of a population of erythrocytes according to age has been 
achieved with varying degrees of success by exploiting age related alterations in 
the cell's surface [1,21, fragility [3] and density [4-8]. A universally accep-
table, simple, rapid, method has, however, yet to be found. Bovine serum 
albumin [4], Stractan II [6] and phthalate esters [7,8] are perhaps the most 
suitable materials that have been employed to construct density gradients, 
while Murphy [9] has fractionated erythrocytes by centrifugation in their own 
plasma. Each of these methods has disadvantages: serum albumin is expensive, 
commercially available Stractan is unacceptably crude, phthalate esters damage 
the cells, and the Murphy method, although it is the gentlest of treatments, 
cannot be directly applied to pathological samples where differences in density 
are accompanied by differences in shape and flexibility. All methods, apart 
from that employing phthalate esters, require prolonged centrifugation. We 
here report the density fractionation of normal healthy human erythrocytes by 
isopycnic centrifugation through gradients of "Percoll", a commercially avail-
able polyvinyl-pyrrolidone-coated colloidal silica. 
Correspondence to: Dr. A.H. Maddy. Department of Zoology, University of Edinburgh. West Mains Road, 
Edinburgh EH9 33T, Scotland. U.K. 
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It is our intention in this report only to establish the effectiveness of the 
method for the age fractionation of erythrocytes, and not to give a comprehen-
sive analysis of the many aspects of erythrocyte physiology related to ageing. 
We have therefore studied a selection of parameters which have been associated 
with ageing. Earlier workers with other techniques of age fractionation have 
shown that mean cell volume (MCV), mean cell haemoglobin concentration 
(MCHC), pyruvate kinase and acetylcholine esterase activities and erythrocyte 
potassium content all change with age. We have found these differences 
between the fractions prepared by centrifugation through "Percoll" gradients. 
We therefore conclude that the "Percoll" gradient is an effective method for 
age fractionation and it will be argued that it possesses certain advantages. 
Methods 
Blood collection 
Blood was obtained by venepuncture from healthy male and female adults. 
Heparin was used as an anticoagulant. 
Preparation of continuous density gradients 
Stock solutions of (a) 5.263% (w/v) bovine serum albumin (BSA) (Cohn frac-
tion V, Sigma Chem. Co.) in water, pH 7.4 and (b) 5.263% BSA in "Percoll" 
(Pharmacia, Fine Chemicals) were made and stored at 4 ° C for no longer than 
3 days. On the day of use, these solutions were equilibrated to room tempera-
ture (18'C), and both solutions were made isotonic, and BSA brought to 5% by 
the addition to (a) of 1 vol 2.66 mol/l NaCl, 0.09 mol/I KC1, 200 mmol/l HEPES 
(N-2-hydroxyethylpiperazine-N'-2-ethane suiphonic acid) buffer pH 7.4, to 19 
vols of the 5.263% BSA in water and to (h) of 1 vol of 2.66 mol/l NaCl, 0.09 
mol/l KC1, 200 mmol/l HEPES, pH 8.5, (the mixture has a final pH of 7.4) to 
19 vols of the 5.263% BSA in "Percoli". 9.5 ml continuous density gradients 
were formed as required from equal volumes of appropriate mixtures of these 
two solutions using a gradient former attached to a peristaltic pump. As cell 
density varied between individuals exploratory gradients were run to establish 
the optimum for each person. Suitable gradients were in the region of 60-70% 
"Percoll". Males tend to have denser cells than females [8]. 
Preparation of erythrocyte suspensions for fractionation 
White cells were removed by what is essentially Beutler's method [101 by 
passing the blood through an a-cellulose: microcrystalline cellulose (2 : 1 w/w) 
column in HEPES buffered isotonic saline (133 mmol/1 NaCI, 4.5 mmoi/l KC1, 
10 mmol/l 1-IEPES, pH 7.4). The haematocrit of the filtered blood was adjusted 
to approximately 30% and the suspension stored at 4 ° C until used. Blood was 
filtered within 2 h of collection and fractionated within 4 h of filtration. 
Age fractionation 
0.5 ml of red cell suspension was brought to room temperature and carefully 
layered on top of a 9.5-ml density gradient. Separation was accomplished by 
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centrifugation at 1100 X g in a swing-out rotor for 5 min at room temperature. 
The centrifuge was slowly decelerated over 5 min to prevent disturbance of the 
gradient. Cells do not change their position in the gradient if the centrifuge 
time is extended, but fractionation deteriorates as there is a tendency for cells 
to clump after longer time intervals. Plasma, which remains at the top of the 
gradient, was removed and the cell fractions then sequentially aspirated from 
the top of the gradient using a Pasteur pipette attached to a peristaltic pump 
and manoeuvred manually over the liquid surface. The cells were finally washed 
free of "Percoll" by 3 washes in HEPES-buffered saline. 
Tests of age fractionation 
Mean cell volume (MCV), mean cell haemoglobin (MCH) and mean cell 
haemoglobin concentration (MCHC) were determined by standard haematologi-
cal procedures using a Coulter-model S. Reticulocyte counts were performed 
by counting at least 1000 cells on films of cells stained supravitally with new 
methylene blue. A whole slide was scanned before a zero count was registered. 
Enzyme assays. Washed cells were lysed with sufficient ice cold 10 mmol/l 
phosphate buffer, pH 7.2, to give a haemolysate of approximately 1.5 g/dl of 
haemoglobin. Haemolysates were stored at —20'C until required for assay. 
Haemoglobin was assayed by its Soret band absorption at 412 nm. Pyruvate 
kinase was determined as described by Beutler [11]. Acetylcholine esterase was 
determined by the Ellman method [12] with dithiobisdinitrobenzoic acid and 
acetylthiocholine at pH 7.4 in a 0.1 mol/l phosphate buffer. 
Cell potassium was measured by flame photometry of lysates made by the 
addition of glass-distilled water to cells which had been rapidly washed free of 
buffered saline with isotonic sucrose. 
Results and discussion 
As "Percoll" is an alien substance, albeit allied to the blood expander poly-
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Fig. 1. The distribution of erythrocytes after centrifugation on a "Percoll" density gradient. For distribu-
tion studies the gradients are separated into 16 fractions of equal volume. In this particular blood sample 
the mode has a density of 1.096. As there are so few cells in the fractions from the two tails these frac-
tions are pooled to provide sufficient cell numbers for other investigations. With experience it is pos-
sible to collect fractions from a gradient so that, if six fractions are desired, they contain approximately 

















Fractions of Increasing density 
Fig. 2. The distribution of reticulocytes in "Percoll" gradients. After separation and washing as described 
in the text, the cells were resuspended in autotogous plasma prior to staining and preparing the slides for 
counting. 
conditions. Consequently we have adjusted tonicity with physiological levels of 
sodium and potassium (but have been obliged to omit divalent ions as they 
cause cell clumping) and added near physiological levels of BSA which assists 
in the maintenance of normal cell morphology. Young cells remain as discs and 
the older cells have a reduced central pallor. 
In common with other workers [4,5] we observe a normal distribution of 
cells along the gradient (Fig. 1). If single fractions are re-centrifuged on fresh 
gradients each shows a narrow distribution centred around the predicted den-
sity. Reticulocytes are concentrated towards the top of gradients [4,5,131 
(Fig. 2), and only very rarely is an occasional reticulocyte seen in the bottom 
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Fig. 4. The increase in mean cell haemoglobin concentration (MCHC) of erythrocytes fractionated on a 
"Percoll" density gradient. 
Mean cell volume, mean cell haemoglobin concentration, pyruvate kinase 
and acetylcholine esterase activities and potassium contents all changed with 
age in the same ways and to the same extents as reported by other workers 
[6,14,15], using different methods (Figs. 3-7). Mean cell haemoglobin content 
remains constant. 
It may be concluded from these results that density fractionations by 
"Percoll" gradients are as good as those achieved by other methods. The major 
advantages of "Percoll" are: (1) the speed of attaining equilibrium (5 min as 
compared with 1-2 h); (2) it allows the density distribution of an erythrocyte 
population to he determined, in particular in pathological cells which may not 
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Fig. 5. The correlation between increased cell density and decreased pyruvate kinase activity of erythro-
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Fig. 6. The correlation between increased cell density and decreased acetylcholine esterase activity of 
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Fig. 7. The correlation between increased cell density and decreased potassium content of erythrocytes 
fractionated on a "Percoll" density gradient. 
and too dense to be separated on other gradient materials without problems of 
high viscosity; (3) gradient density may be easily varied at will; and (4) it is 
relatively inexpensive and available commercially in a pure, sterile state. The 
simplicity of the method suggests that it might be adapted for clinical diag-
nostic purposes, and the quantities of cells separated are sufficient for studying 
erythrocyte ageing both in intact cells and in cell membranes. 
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Summary 
Surface proteins and glycoproteins of intact human red blood cells were 
labelled with 125J  by the lactoperoxidase method. The radioactive proteins were 
then separated in each of the Fairbanks and Laemmli one-dimensional poiy-
acrylamide gel electrophoresis systems. The radioactive polypeptides had dif-
ferent mobilities in the two systems, largely due to the anomalous migration of 
glycoproteins in polyacrylamide gels. A two-dimensional system was therefore 
developed using the Fairbanks and Laemmli buffer systems to exploit these 
anomalies. This procedure clearly resolved radioactive glycoproteins and 
proteins and enabled the identification of many more surface components than 
had previously proved possible. 
Introduction 
Many techniques have been developed to label surface components of ery-
throcyte membranes [1-3]. Techniques utilising radioactive iodine have proved 
to be the most popular, presumably due to the ease of detection of radioactive 
iodine in labelled proteins after their separation in polyacrylamide gels. The 
best known, and most used, of these techniques is the lactoperoxidase-
catalysed iodination procedure using H 202 directly [4] or H 202 generated by 
the glucose-glucose oxidase system [5]. Other techniques utilising radioactive 
iodine involve the direct covalent binding of radioactively labelled chemicals, 
often diazonium salts, to surface proteins [6,7]. More recently, another 
iodinating reagent, chioroglycoluril, has been used to label erythrocyte surface 
To whom correspondence should be addressed. 
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proteins [8]. Surprisingly, relatively few membrane proteins have been shown 
to have a surface orientation in intact red blood cells by these techniques and 
such a simplicity is inconsistent with the many functions that may be 
attributed to the cell's surface [9]. Other techniques [10,11], especially 
tritiation of the surface carbohydrates [12,13], have revealed many more 
components. The apparent discrepancies could result from several factors, 
variation in the susceptibility of different surface groups to different labelling 
techniques, variation in fractionation of labelled components, and aggregation 
of labelled components. 
The commonest fractionation procedure used to study surface labelled 
groups is sodium sulphate (SDS) gel electrophoresis in various guises, and 
although it is well known that glycoproteins behave anomalously in these 
systems [14] frequently insufficient attention is paid to these anomalies. 
Here we compare the fractionation of erythrocyte membrane proteins by two 
well-established gel buffer systems, those of Fairbanks et al. [15] and Laemmli 
[16], and combine the two methods into a two-dimensional technique which 
exploits the effects of gel matrix and buffer on the mobilities of glycoproteins. 
This combination results in a much more complex pattern of labelled proteins 
after lactoperoxidase-catalysed iodination than has previously been described 
as it reveals many components which are obscured when either buffer system is 
used alone. Some of the complexity can be interpreted in terms of glycoprotein 
aggregations which have been reported elsewhere [17]. 
Materials and Methods 
Materials 
125J as Na' 25 1 in dilute NaOH was purchased from the Radiochemical Centre 
(Amersham, Bucks, U.K.). Biochemicals and enzymes were purchased from 
Sigma Chemical Co. (St. Louis, MO, U.S.A.). Chemicals were of analytical 
grade and were obtained from BDH Chemicals Limited (Poole, Dorset, U.K.). 
Methods 
Preparation of erythrocyte suspensions for 125f labelling. Blood was obtained 
by venipuncture from healthy male and female adults using heparin as an anti-
coagulant. White cells were removed by using the method of Beutler et al. 
[18]. The blood was passed through an a-cellulose/microcrystalline cellulose 
(2: 1, w/w) column in Hepes-buffered isotonic saline (133 mM NaC1, 4.5 mM 
KCI, 10 mM Hepes, pH 7.4) [19]. The filtered blood was washed three times in 
the same Hepes-buffered isotonic saline and then labelled with 1251.  Blood was 
iodinated within 3 h of collection. 
Surface labelling with 125j  Lactoperoxidase-catalysed iodination was carried 
out using H 20 2 generated by the glucose oxidase system of Hubbard and Cohn 
[5]. 1 ml of incubation mixture contained 5. 108  cells in Hepes-buffered 
isotonic saline, 5 mM glucose, 0.1 ig glucose oxidase (Sigma, Type V), 10 jig 
lactoperoxidase (Sigma, powder), 0.5 pM K' 271 and 50 pCi of Na' 25 1: (in our 
experience, 0.5 pM K' 271 gave the maximal level of iodination). Incubations 
were carried out for 20 min at 37 ° C then the reaction was terminated by the 
addition of 10-ml of Hepes-buffered isotonic saline (4 0 C) containing 10 pM 
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Na2S205 : ( all subsequent operations were performed at 4 C C). The cells were 
washed three times with 12-ml of this buffer and twice with 12-ml of this 
buffer containing 5 pM K! to remove any free Na' 25 !. Ghosts were prepared 
by lysing the cells in 12-ml of 5 mM phosphate buffer (pH 7.2) and centri-
fuging the resulting suspension at 38 000 X g for 25 min. The pink ghosts were 
then washed in 12-ml of 5 mM phosphate buffer (pH 7.5) and recentrifuged. 
The resultant off-white ghost pellet was prepared for electrophoresis by the 
addition of 1 vol. of 0.125 M Tris-HC1, pH 6.8, containing 10% (w/v) SDS, 
20% glycerol, 0.002% bromophenol blue, 1 mM EDTA and 80 mM dithio-
threitol to 1 vol. of ghosts. This mixture was immediately heated for 5 min at 
100° C to inactivate proteases and maximise protein solubilisation. 
One-dimensional polyacrylamide gel electrophoresis. Proteins were separated 
by SDS-polyacrylamide gel electrophoresis in the continuous buffer system 
described by Fairbanks et al. [15] or the discontinuous buffer system described 
by Laemmli [16]. The slab gel apparatus used was that first described by Reid 
and Bieleski [20] and later modified by Studier [21]. The slab gels were 15 cm 
wide, 14 cm high and 1.5 mm thick. A 14-sample comb was used, each sample 
well 7 mm wide, 15 mm deep and 3 mm apart. In the system of Fairbanks, 
the acrylamide stock solution contained 40% (w/v) acrylamide and 1.5% (w/v) 
bis-acrylamide. This was used to make linear gradient acrylamide slabs from 
4-6% acrylamide. Electrophoresis took approx. 4 h at a constant current of 
40 mA. In the discontinuous buffer system of Laemmii, the acrylamide stock 
solution was 30% acrylamide and 0.8% bis-acrylamide. This was used to prepare 
running gels of 11.5% acrylamide and stacking gels of 5% acrylamide. Electro-
phoresis took approx. 4 h at a constant current of 30 mA. Pre-set Tris-HC1 
crystals (pH 8.7 at 25'C, Sigma) were used to make up the running-gel buffer; 
this was essential for reproducible high-resolution gels. The total polypeptide 
content of the cells was determined by staining the gels with Coomassie 
brilliant blue [15]. Radioactive polypeptides were detected by autoradiography 
of the dried gels. 
Two-dimensional gel electrophoresis. To produce a two-dimensional gel of 
erythrocyte ghost proteins the protein samples were first run in a one-dimen-
sional Fairbanks slab gel (1.5 mm thick) with empty sample wells between 
samples. After electrophoresis, strips (7-8 mm wide) containing the samples 
were cut from the acrylamide slab. These strips were equilibrated for 30 mm 
in Laemmli sample buffer containing 0.0625 M Tris-HC1, pH 6.8, 5% (w/v) 
SDS, 10% (w/v) glycerol, 0.5 mM EDTA and 5% (v/v) mercaptoethanol. After 
equilibration the strips could be run in the second (Laemmli) dimension 
immediately or stored frozen at —20 0 C for up to 2 or 3 weeks. Longer periods 
of storage led to dehydration and shrinkage. Second-dimension Laemmli gels 
(1.75 mm thick) were prepared as for one-dimensional gels except that the 
stacking gel was 1.5 cm high with a flat surface which was itself 1 cm below 
the buffer surface. A strip from the Fairbanks gel was then pushed into the 
space above the stacking gel, fixed into position with 1.0% (w/v) agarose in 
electrode buffer containing 0.001% bromophenol blue as a marker dye and 
subjected to electrophoresis. 
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Results and Discussion 
Iodination of the red cells 
Under the conditions described in Methods with 0.5 MM K' 271, the radio-
active iodine incorporation into membrane surface proteins was approx. 
3 10 dpm/mg of protein. At 1.5 pM or 0 pM K' 271, the radioactive iodine 
incorporation dropped by 65 and 25%, respectively. Non-specific labelling 
(control without any lactoperoxidase) was less than 0.5%. 
Polyacrylamide gel electrophoresis in the Fairbanks system 
The continuous buffer system of Fairbanks et al. [15] has been the most 
widely used system for the examination of erythrocyte proteins in recent years. 
We therefore separated our labelled membrane proteins in this system for 
direct comparison with other studies. Fig. 1 compares the total polypeptide 
content of the erythrocytes with those labelled with radioactive iodine. This 
A 	B 	 C 
IM — 
Hb 	 Hb + DF - 
Fig. 1. (A) The total polypeptide content by Coomassie staining of erythrocyte membranes separated 
by the Fairbanks system, and (B) autoradiograph of the radioactive iodine-labelled surface polypeptides 
of A. (C) The total polypeptide content of erythrocyte membranes separated by the Laemmli system, 
and (D) autoradiograph of the radioactive iodine-labelled surface polypeptides of C. Polypeptides are 
numbered as in the Fairbanks system. Hb = haemoglobin; DF = dye front. 
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labelling agrees very well with that obtained in other studies [7,8,22,23] 
through which we can identify one of the labelled peptides in band 3 as PAS 1 
and the labelled peptides in the 4.5 and 7 positions as PAS 2 and PAS 2, 
respectively. These assignments are confirmed and amplified by our two-
dimensional system (see below), as is the apparently anomalous labelling 
coincident with actin (band 5). 
Polyacrylamide gel electrophoresis in the Laemmli system 
The total polypeptide content of erythrocytes and the radioactively labelled 
surface proteins obtained when labelled membranes were separated in the 
system described by Laemmli are also shown in Fig. 1. The Laemmli system 
gives a much better resolution than the Fairbanks system and many differences 
can be seen between the polypeptide patterns produced by the two systems. 
In Laemmli gels there is no 2.1 band, band 3 stains as a broad rather diffuse 
band containing sharp discrete bands within it, band 4.1 is always a doublet 
[24], up to 15 polypeptides can be clearly detected between bands 4.2 and 
5, making the '4.5 region' very complex, and an extra band above band 7 
(labelled as 6.9) is always present. To allow comparison with other studies that 
have used the Laemmli polyacrylamide gel system [8,13,24,251 two relatively 
strong bands in the 4.5 region are labelled as 4.5a and 4.5b. Band 4.5a migrates 
fractionally slower than catalase and is the strongest band in the 4.5 region in 
incompletely washed (pink) normal ghosts and in ghosts obtained from patients 
with hereditary spherocytosis, it is, in fact, a major constituent of the cyto-
plasm. Band 4.5b migrates fractionally faster than catalase and is the strongest 
band in the 4.5 region in completely washed (white) normal ghosts (Thompson, 
S. and Maddy, A.H., unpublished results). Band 6.9 is extracted along with 
spectrin (bands 1 and 2) and actin (band 5) when erythrocyte ghosts are 
dialysed overnight against 0.5 mM EDTA and is, presumably, the component 
designated as band 7 in the spectrin extract of Dunbar and Ralston [261. Up 
to 20 surface-labelled polypeptide bands can be seen in autoradiograph of the 
one-dimensional gel. 
When the four most radioactive polypeptide bands (PAS 1, PAS 2, PAS 3 
and band 3) are compared between each gel system, as would be predicted 
from the literature [14,27], they have different relative mobilities. In 
Fairbanks gels at the concentration used here, PAS 1, 2 and 3 have apparent 
molecular weights of 95 000, 55000 and 29000, respectively; in Laemmli gels 
they migrate with apparent molecular weights of 80000, 38 000 and 24000. 
We therefore decided to exploit this anomalous migration of the glycoproteins 
and to subject the labelled proteins to a combination of the two buffers as a 
two-dimensional system. Such a technique would be expected to separate 
labelled glycoproteins from each other and from any labelled proteins which 
co-migrate with them in either of the two one-dimensional systems. 
Two-dimensional polyacrylamide gel electrophoresis 
Erythrocyte protein samples were separated in two dimensions as described 
in Methods. A Coomassie blue-stained two-dimensional gel does not give very 
much extra detail compared with a one dimensional Laemmli gel (Fig. 2). It 
does, however, show that the Fairbanks 2.1 component runs as a band 1 corn- 
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Fig. 2. The two-dimensional Coomassie-staining pattern of erythrocyte membrane polypeptides. Inset: 
1, 2 and 2.1 region at a lower protein loading. 
ponent in Laemmli gels, hence explaining the lack of a 2.1 band in Laemmli 
gels. Band 3 is also seen to migrate as a large diffuse area away from the main 
polypeptide arc, presumably because of its carbohydrate content [28,29]. Four 
or five small spots are seen on the polypeptide arc in positions where the broad 
band 3 obscures them in one-dimensional systems. This heterogeneity might 
account for some of the apparent multiplicity of function of the band 3 
region. 
The autoradiographed gel (Fig. 3) is much more informative, revealing more 
than 50 surface-labelled components. The strongest radioactivity is associated 
with components that do not stain well with Coomassie blue, only four of the 
radioactive spots (bands 3, 4.5a, 4.5b and haemoglobin, Fig. 4) are stained. The 
Fig. 3. Autoradiographs of surface-labelled components of erythrocyte membranes. (a) Short exposure, 



































Fig. 4. A comparison of the surface-labelled components and the total polypeptides content of the 
erythrocyte membranes. Coomassie-staining components in black. 
PAS bands only stain with Coomassie blue on heavily loaded gels and the 
colour has a reddish tinge when compared with the blue of other proteins. As 
material in the 4.5a position can be derived from the cytoplasm we initially 
concluded that 4.5a is a cytoplasmic protein and, consequently, should not be 
labelled. However, if one-dimensional Laemmli gels containing 16% acrylamide 
and 0.1% bis-acrylamide are used, 4.5a is resolved into two bands, only one of 
which is labelled. We therefore conclude that 4.5a contains surface and cyto-
plasmic polypeptides. Actin (band 5) is not labelled, although the paradox 
of radioactivity in the position of band 5 in one-dimensional gels has been 
reported [30] and confirmed here. The two-dimensional gel shows that, in both 
Fairbanks and Laemmli systems, this radioactivity is actually due to various 
minor glycoproteins. Slight traces of label are found in the spectrin and haemo-
globin regions, but in comparison with the quantities of these proteins present 
their specific activities are extremely low. In the gels illustrated the haemo-
globin moves with the buffer front and its radioactivity is elevated by unidenti-
fied, dialysable, fast-moving radioactive substances which are separated from it 
on gels of higher acrylamide concentration. Although no haemoglobin is 
observed leaching from cells during labelling, and the small amount of radio- 
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activity would probably pass unnoticed in other gel systems, especially when 
gels have been sliced for counting, this radioactivity could represent a degree 
of leakage of the erythrocytes. 
The PAS bands 1, 2, 3 and 4 of the Fairbanks dimension each resolve into 
several components in the Laemmli second dimension (Fig. 5). 
The major components of PAS 1 and 2 form a rectangle which we interpret 
as the two interconvertible forms of PAS 1 and 2 which have been reported 
[14,31]. It is probable that these PAS 1 and 2 components represent the 
dimeric and monomeric forms of the same major erythrocyte glycoprotein 
(glycophorin A) both of which might exist in the membrane [32]. Glycophorin 
A (Fig. 6a) can also contribute to PAS 4 [33]. Although the two glycoprotein 
A components comprise the vast majority of the PAS 1 band, the PAS 2 band 
contains another family of glycoproteins. This family of glycoproteins 
probably represents part of glycophorin B (Fig. 6b) reported by Furthmayr 
et al. [17] (the PAS 2' components of Mueller and Morrison [221) and can 
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Fig. 5. The components formed in the Laemmli second dimension from PAS bands 1, 2. 3 and 4 of the 
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Fig. 6. (a—c) Diagrams illustrating the probable relationship between the PAS bands 1-4 and the glyco-
phorins A, B and C, respectively. The relationships postulated between the PAS bands and the three 
glycophorins depend upon observed co-migration of components and the report by Furthmayr et al. 
[17] that glycophorin A runs predominantly in the position of PAS 1 with a lesser component as PAS 2, 
that glycophorin B runs predominantly as PAS 2 with minor components in positions PAS 1 and PAS 4, 
and that glycophorin C runs chiefly as PAS 2 and PAS 3 with a trace of PAS 4. (d) Radioactive surface-
labelled components which cannot be assigned to the glycophorins. 
to PAS 1 glycoproteins [34,351. The PAS 3 band appears to be a fairly discrete 
entity comprising one family of glycoproteins which are probably the major 
constituents of glycophorin C (Fig. 6c). PAS 4 is made up of traces of glyco-
proteins which run predominantly in the PAS 1, 2 and 3 positions. This agrees 
with earlier evidence presented by Tanner [271. Our allocations of labelled 
components to specific glycoproteins is confirmed by the method of Hama-




surface-labelled glycoproteins extracted are shown in Fig. 7. The major labelled 
glycoprotein extracted is glycophoriri A (PAS 1 and 2), although another PAS 
4 component is also extracted. This agrees with the result of Luthra et al. 
[301 who also examined extracted glycoproteins from surface-labelled mem-
branes. 
Our conclusion that the many high molecular weight components resolved 
from PAS 2 and 3 in the second dimension are aggregates of the relatively low 
molecular weight glycophorins B and C, depends upon the reports that these 
glycophorins can form SDS-resistant aggregates E17,371. However, it is diffi-
cult to explain how these seemingly large complexes in the Laemmli gels move 
as small entities in the Fairbanks gel. Careful examination shows that the 
molecular weights (or at least electrophoretic mobilities) of the aggregates of 
glycophonns B and C are not identical, which suggests that the two glyco-
phorins are distinct, albeit similar, molecules. The mobilities of the aggregates 
of C are logarithmically related, but the inter-relationships within the B zone 
are more complex as additional components are present. 
Fig. 6d illustrates the many labelled components that cannot be assigned to 
the glycophorins or band 3. Most appear as diffuse areas of radioactivity, but 
the pattern is highly reproducible between different blood samples. 




Fig. 7. Autoradiograph of a two-dimensional gel of the surface-labelled glycoproteins extracted by the 
method of }Iamaguchi and Cleve [36J. Virtually all of the activity is confined to glycophorm A (Fig. 
6a). 
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that the diversity of results obtained by different labelling techniques is a con-
sequence of the variation in the activity of the exposed groups to the different 
labels. The diverse results are succinctly described by Sears et al. [7]. 
Generally, lactoperoxidase has appeared to label rather few components, while 
tritiation after galactose oxidase treatment has labelled many components. This 
discrepancy may result from the fact that the galactose oxidase tritiates 
exposed glycosyl residues and lactoperoxidase the exposed polypeptide chains, 
but the disparity may also arise partially from the differing resolving powers of 
the gels used by the various authors to fractionate the labelled membranes. 
It is apparent from our results that a complex labelling pattern is obtainable 
after lactoperoxidase labelling. The complexity does not appear to be a con-
sequence of proteolysis. The membranes are boiled in the presence of SDS as 
soon as they have been prepared and addition of phenylmethylsulphonyl 
fluoride plus EDTA during lysis and washing procedures has no effect on the 
pattern. The pattern is highly reproducible between the eight individuals so far 
examined with the exception that the relative amounts of the high molecular 
weight aggregates in the Laemmli dimension can vary slightly between samples 
of the same individual prepared on different days. 
The two-dimensional system described in this report greatly facilitates the 
identification of surface-labelled components and should be of particular value 
in the study of membrane glycoproteins. The two-dimensional gels clearly show 
that conflicting results can be obtained from the same labelled membane 
preparation by different one-dimensional systems. Combination of the two 
SDS gel systems also clarifies some ambiguities of nomenclature which have 
been caused by the application of a band nomenclature developed for the 
Fairbanks gel to the Laemmli system. 
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